
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B37B192646AC33C37B1004C443153.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cancers">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancers">
<meta name="citation_title" content="Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance">
<meta name="citation_author" content="Elisa Gelli">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author" content="Mara Colombo">
<meta name="citation_author_institution" content="Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)">
<meta name="citation_author" content="Anna Maria Pinto">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Giovanna De Vecchi">
<meta name="citation_author_institution" content="Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)">
<meta name="citation_author" content="Claudia Foglia">
<meta name="citation_author_institution" content="Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)">
<meta name="citation_author" content="Sara Amitrano">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Valeria Morbidoni">
<meta name="citation_author_institution" content="Department of Woman and Child Health, University of Padova, 35128 Padova, Italy; valeria.morbidoni@gmail.com (V.M.); eva.trevisson@unipd.it (E.T.)">
<meta name="citation_author_institution" content="Istituto di Ricerca Pediatrica, IRP, Città della Speranza, 35129 Padova, Italy">
<meta name="citation_author" content="Valentina Imperatore">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author" content="Siranoush Manoukian">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Siranoush.Manoukian@istitutotumori.mi.it">
<meta name="citation_author" content="Margherita Baldassarri">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Caterina Lo Rizzo">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Lorenza Catania">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author" content="Elisa Frullanti">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author" content="Enrico Tagliafico">
<meta name="citation_author_institution" content="Department of Medical and Surgical Science, Center for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, Italy; enrico.tagliafico@unimore.it">
<meta name="citation_author" content="Laura Cortesi">
<meta name="citation_author_institution" content="Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, 41124 Modena, Italy; cortesi.laura@aou.mo.it (L.C.); hbc@unimore.it (F.S.)">
<meta name="citation_author" content="Federica Spaggiari">
<meta name="citation_author_institution" content="Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, 41124 Modena, Italy; cortesi.laura@aou.mo.it (L.C.); hbc@unimore.it (F.S.)">
<meta name="citation_author" content="Maria Antonietta Mencarelli">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Eva Trevisson">
<meta name="citation_author_institution" content="Department of Woman and Child Health, University of Padova, 35128 Padova, Italy; valeria.morbidoni@gmail.com (V.M.); eva.trevisson@unipd.it (E.T.)">
<meta name="citation_author_institution" content="Istituto di Ricerca Pediatrica, IRP, Città della Speranza, 35129 Padova, Italy">
<meta name="citation_author" content="Paolo Radice">
<meta name="citation_author_institution" content="Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)">
<meta name="citation_author" content="Alessandra Renieri">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_author" content="Francesca Ariani">
<meta name="citation_author_institution" content="Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)">
<meta name="citation_author_institution" content="Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)">
<meta name="citation_publication_date" content="2019 Mar 1">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="295">
<meta name="citation_doi" content="10.3390/cancers11030295">
<meta name="citation_pmid" content="30832263">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/pdf/cancers-11-00295.pdf">
<meta name="description" content="Highly penetrant variants of BRCA1/2 genes are involved in hereditary predisposition to breast and ovarian cancer. The detection of pathogenic BRCA variants has a considerable clinical impact, allowing appropriate cancer-risk management. However, a ...">
<meta name="og:title" content="Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Highly penetrant variants of BRCA1/2 genes are involved in hereditary predisposition to breast and ovarian cancer. The detection of pathogenic BRCA variants has a considerable clinical impact, allowing appropriate cancer-risk management. However, a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="6468917">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/cancers11030295"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cancers-11-00295.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6468917%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/6468917/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/6468917/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cancers.png" alt="Cancers logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cancers" title="Link to Cancers" shape="default" href="http://www.mdpi.com/journal/cancers" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancers (Basel)</button></div>. 2019 Mar 1;11(3):295. doi: <a href="https://doi.org/10.3390/cancers11030295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/cancers11030295</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cancers%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancers%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancers%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancers%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of <em>BRCA1/2</em> Variants of Uncertain Significance</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gelli%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Elisa Gelli</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Elisa Gelli</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gelli%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisa Gelli</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colombo%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mara Colombo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mara Colombo</span></h3>
<div class="p">
<sup>2</sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Colombo%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mara Colombo</span></a>
</div>
</div>
<sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pinto%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Anna Maria Pinto</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Anna Maria Pinto</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pinto%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna Maria Pinto</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Vecchi%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Giovanna De Vecchi</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Giovanna De Vecchi</span></h3>
<div class="p">
<sup>2</sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Vecchi%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giovanna De Vecchi</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Foglia%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Claudia Foglia</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Claudia Foglia</span></h3>
<div class="p">
<sup>2</sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Foglia%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia Foglia</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amitrano%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Sara Amitrano</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Sara Amitrano</span></h3>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Amitrano%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sara Amitrano</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Morbidoni%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Valeria Morbidoni</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Valeria Morbidoni</span></h3>
<div class="p">
<sup>4</sup>Department of Woman and Child Health, University of Padova, 35128 Padova, Italy; valeria.morbidoni@gmail.com (V.M.); eva.trevisson@unipd.it (E.T.)</div>
<div class="p">
<sup>5</sup>Istituto di Ricerca Pediatrica, IRP, Città della Speranza, 35129 Padova, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Morbidoni%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valeria Morbidoni</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Imperatore%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Valentina Imperatore</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Valentina Imperatore</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Imperatore%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Valentina Imperatore</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Siranoush Manoukian</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Siranoush Manoukian</span></h3>
<div class="p">
<sup>6</sup>Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Siranoush.Manoukian@istitutotumori.mi.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siranoush Manoukian</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baldassarri%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Margherita Baldassarri</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Margherita Baldassarri</span></h3>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baldassarri%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Margherita Baldassarri</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo%20Rizzo%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Caterina Lo Rizzo</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Caterina Lo Rizzo</span></h3>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lo%20Rizzo%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Caterina Lo Rizzo</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Catania%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Lorenza Catania</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Lorenza Catania</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Catania%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lorenza Catania</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frullanti%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Elisa Frullanti</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Elisa Frullanti</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frullanti%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisa Frullanti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tagliafico%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Enrico Tagliafico</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Enrico Tagliafico</span></h3>
<div class="p">
<sup>7</sup>Department of Medical and Surgical Science, Center for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, Italy; enrico.tagliafico@unimore.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tagliafico%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Enrico Tagliafico</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cortesi%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Laura Cortesi</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Laura Cortesi</span></h3>
<div class="p">
<sup>8</sup>Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, 41124 Modena, Italy; cortesi.laura@aou.mo.it (L.C.); hbc@unimore.it (F.S.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cortesi%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura Cortesi</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spaggiari%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Federica Spaggiari</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Federica Spaggiari</span></h3>
<div class="p">
<sup>8</sup>Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, 41124 Modena, Italy; cortesi.laura@aou.mo.it (L.C.); hbc@unimore.it (F.S.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spaggiari%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Federica Spaggiari</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mencarelli%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Maria Antonietta Mencarelli</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Maria Antonietta Mencarelli</span></h3>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mencarelli%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Antonietta Mencarelli</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trevisson%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Eva Trevisson</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Eva Trevisson</span></h3>
<div class="p">
<sup>4</sup>Department of Woman and Child Health, University of Padova, 35128 Padova, Italy; valeria.morbidoni@gmail.com (V.M.); eva.trevisson@unipd.it (E.T.)</div>
<div class="p">
<sup>5</sup>Istituto di Ricerca Pediatrica, IRP, Città della Speranza, 35129 Padova, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Trevisson%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eva Trevisson</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Radice%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Paolo Radice</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Paolo Radice</span></h3>
<div class="p">
<sup>2</sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Radice%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paolo Radice</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Renieri%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Alessandra Renieri</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Alessandra Renieri</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Renieri%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alessandra Renieri</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ariani%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Francesca Ariani</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Francesca Ariani</span></h3>
<div class="p">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div class="p">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ariani%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Ariani</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-cancers-11-00295">
<sup>1</sup>Medical Genetics, University of Siena, 53100 Siena, Italy; elisa.gelli@student.unisi.it (E.G.); annamaria.pinto@dbm.unisi.it (A.M.P.); va.imperatore@gmail.com (V.I.); catania4@student.unisi.it (L.C.); elisa.frullanti@dbm.unisi.it (E.F.); francesca.ariani@unisi.it (F.A.)</div>
<div id="af2-cancers-11-00295">
<sup>2</sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Mara.Colombo@istitutotumori.mi.it (M.C.); giovanna.devecchi@cogentech.it (G.D.V.); Claudia.Foglia@istitutotumori.mi.it (C.F.); Paolo.Radice@istitutotumori.mi.it (P.R.)</div>
<div id="af3-cancers-11-00295">
<sup>3</sup>Genetica medica Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy; sara.amitrano@dbm.unisi.it (S.A.); margherita.baldassarri@dbm.unisi.it (M.B.); lorizzo2@unisi.it (C.L.R.); mariaantonietta.mencarelli@unisi.it (M.A.M.)</div>
<div id="af4-cancers-11-00295">
<sup>4</sup>Department of Woman and Child Health, University of Padova, 35128 Padova, Italy; valeria.morbidoni@gmail.com (V.M.); eva.trevisson@unipd.it (E.T.)</div>
<div id="af5-cancers-11-00295">
<sup>5</sup>Istituto di Ricerca Pediatrica, IRP, Città della Speranza, 35129 Padova, Italy</div>
<div id="af6-cancers-11-00295">
<sup>6</sup>Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy; Siranoush.Manoukian@istitutotumori.mi.it</div>
<div id="af7-cancers-11-00295">
<sup>7</sup>Department of Medical and Surgical Science, Center for Genome Research, University of Modena and Reggio Emilia, 41125 Modena, Italy; enrico.tagliafico@unimore.it</div>
<div id="af8-cancers-11-00295">
<sup>8</sup>Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, 41124 Modena, Italy; cortesi.laura@aou.mo.it (L.C.); hbc@unimore.it (F.S.)</div>
<div class="author-notes p">
<div class="fn" id="c1-cancers-11-00295">
<sup>*</sup><p class="display-inline">Correspondence: <span>alessandra.renieri@unisi.it</span>; Tel.: +39-0577-233303; Fax: +39-0577-233325</p>
</div>
<div class="fn" id="fn1-cancers-11-00295">
<sup>†</sup><p class="display-inline">These authors equally contributed to the manuscript.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2019 Jan 11; Accepted 2019 Feb 20; Collection date 2019 Mar.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2019 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC6468917  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30832263/" class="usa-link">30832263</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Highly penetrant variants of <em>BRCA1/2</em> genes are involved in hereditary predisposition to breast and ovarian cancer. The detection of pathogenic BRCA variants has a considerable clinical impact, allowing appropriate cancer-risk management. However, a major drawback is represented by the identification of variants of uncertain significance (VUS). Many VUS potentially affect mRNA splicing, making transcript analysis an essential step for the definition of their pathogenicity. Here, we characterize the impact on splicing of ten <em>BRCA1/2</em> variants. Aberrant splicing patterns were demonstrated for eight variants whose alternative transcripts were fully characterized. Different events were observed, including exon skipping, intron retention, and usage of de novo and cryptic splice sites. Transcripts with premature stop codons or in-frame loss of functionally important residues were generated. Partial/complete splicing effect and quantitative contribution of different isoforms were assessed, leading to variant classification according to Evidence-based Network for the Interpretation of Mutant Alleles (ENIGMA) consortium guidelines. Two variants could be classified as pathogenic and two as likely benign, while due to a partial splicing effect, six variants remained of uncertain significance. The association with an undefined tumor risk justifies caution in recommending aggressive risk-reduction treatments, but prevents the possibility of receiving personalized therapies with potential beneficial effect. This indicates the need for applying additional approaches for the analysis of variants resistant to classification by gene transcript analyses.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> splicing, BRCA, mRNA analysis, VUS</p></section></section><section id="sec1-cancers-11-00295"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Breast cancer (BC) represents a priority public health problem, being the most common cancer diagnosed in women worldwide and a leading cause of cancer deaths [<a href="#B1-cancers-11-00295" class="usa-link" aria-describedby="B1-cancers-11-00295">1</a>,<a href="#B2-cancers-11-00295" class="usa-link" aria-describedby="B2-cancers-11-00295">2</a>,<a href="#B3-cancers-11-00295" class="usa-link" aria-describedby="B3-cancers-11-00295">3</a>]. The most relevant predisposing factor is family history. The risk increases with the number of affected relatives and the age of cancer onset. Approximately 5–10% of BC cases are associated with a strong hereditary component and 15–25% of familial aggregations are due to mutations in the <em>BRCA1</em> (MIM# 113705) or <em>BRCA2</em> (MIM# 600185) genes [<a href="#B4-cancers-11-00295" class="usa-link" aria-describedby="B4-cancers-11-00295">4</a>,<a href="#B5-cancers-11-00295" class="usa-link" aria-describedby="B5-cancers-11-00295">5</a>,<a href="#B6-cancers-11-00295" class="usa-link" aria-describedby="B6-cancers-11-00295">6</a>,<a href="#B7-cancers-11-00295" class="usa-link" aria-describedby="B7-cancers-11-00295">7</a>]. Recent estimates have assessed that women who inherit a mutation in <em>BRCA1</em> have a chance of 72% (95% confidence interval (CI), 65–79%) of developing BC and of 44% (95% CI, 36–53%) of developing ovarian cancer (OC) in their lifetime. In <em>BRCA2</em> mutation carriers the percentages are similar for BC (44%; 95% CI, 36–53%), but lower for OC (17%; 95% CI, 11–25%) [<a href="#B8-cancers-11-00295" class="usa-link" aria-describedby="B8-cancers-11-00295">8</a>]. BRCA gene mutations may also predispose to the development of other cancers, such as endometrial, pancreatic, colorectal, gastric, and skin cancer [<a href="#B9-cancers-11-00295" class="usa-link" aria-describedby="B9-cancers-11-00295">9</a>,<a href="#B10-cancers-11-00295" class="usa-link" aria-describedby="B10-cancers-11-00295">10</a>]. Genetic testing is thus essential to identify at-risk individuals who can undergo paths aimed at ensuring early diagnosis and/or at reducing the risk of cancers, including prophylactic surgery (mastectomy and/or oophorectomy). Moreover, it has been demonstrated that patients with BRCA mutation and OC present a significantly more favorable prognosis and pharmacological sensitivity to treatment with inhibitors of the enzyme poly (ADP-ribose) polymerase (PARP) [<a href="#B11-cancers-11-00295" class="usa-link" aria-describedby="B11-cancers-11-00295">11</a>].</p>
<p>The use of BRCA mutation testing for purposes of therapeutic choices implies that genetic testing is easily accessible for all patients who could benefit and that results are available in a timeframe consistent with the clinical need. Next-generation sequencing (NGS) platforms, allowing the simultaneous analysis of multi-gene panels, have significantly decreased the time required for genetic testing, but a major critical issue for clinical application of results is still represented by variant interpretation. Despite the testing of hundreds of thousands of patients worldwide, there is a significant percentage (5–20%) of <em>BRCA1/2</em> sequence changes that are classified as variants of uncertain significance (VUS), i.e., alterations for which there is insufficient evidence of the effects on the function of the gene product and disease risk [<a href="#B12-cancers-11-00295" class="usa-link" aria-describedby="B12-cancers-11-00295">12</a>]. Variant classification has greatly improved through the research efforts of multidisciplinary international consortia such as the Evidence-based Network for the Interpretation of Mutant Alleles (ENIGMA; <a href="http://enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://enigmaconsortium.org/</a>), which has collected evidence on a large-scale basis, and through the application of multifactorial likelihood models that take into account tumor characteristics and family-based genetic data [<a href="#B13-cancers-11-00295" class="usa-link" aria-describedby="B13-cancers-11-00295">13</a>]. However, given the large size of the <em>BRCA1/2</em> genes, many VUS are unique to only one or few patients and the amount of data required for a reliable classification by multifactorial models is often lacking.</p>
<p>It has been previously demonstrated that many <em>BRCA1/2</em> variants affect mRNA and generate abnormal splicing products [<a href="#B14-cancers-11-00295" class="usa-link" aria-describedby="B14-cancers-11-00295">14</a>]. These variants are able to alter intronic splicing elements such as the 5’ and 3’ consensus sequences, the so-called “Cartegni consensus regions” [<a href="#B15-cancers-11-00295" class="usa-link" aria-describedby="B15-cancers-11-00295">15</a>], or exonic/intronic regulatory elements; they can also introduce de novo splice sites or lead to the activation of cryptic splice sites. The resulting aberrant transcript(s) can present partial/entire intronic retention or exon exclusion with production of a premature termination codon (PTC) in most cases. This evidence of a dysfunctional role for the identified variants can thus overcome the need for additional data required for multifactorial likelihood analysis. Different in silico tools have been developed to predict the consequences of intronic/exonic variants on normal mRNA splicing and select them for in vitro studies [<a href="#B16-cancers-11-00295" class="usa-link" aria-describedby="B16-cancers-11-00295">16</a>,<a href="#B17-cancers-11-00295" class="usa-link" aria-describedby="B17-cancers-11-00295">17</a>,<a href="#B18-cancers-11-00295" class="usa-link" aria-describedby="B18-cancers-11-00295">18</a>]. However, their predictions have been demonstrated to be highly reliable for variants located in Cartegni-consensus regions, but less accurate for variants lying in elements such as the exonic splicing enhancer (ESE) or branchpoints [<a href="#B19-cancers-11-00295" class="usa-link" aria-describedby="B19-cancers-11-00295">19</a>]. Laboratory tests, including transcript analysis and minigene assay, have been demonstrated to represent powerful tools to assess pathogenicity of potential spliceogenic variants and remain mandatory for the characterization of aberrant transcripts [<a href="#B14-cancers-11-00295" class="usa-link" aria-describedby="B14-cancers-11-00295">14</a>,<a href="#B20-cancers-11-00295" class="usa-link" aria-describedby="B20-cancers-11-00295">20</a>,<a href="#B21-cancers-11-00295" class="usa-link" aria-describedby="B21-cancers-11-00295">21</a>,<a href="#B22-cancers-11-00295" class="usa-link" aria-describedby="B22-cancers-11-00295">22</a>,<a href="#B23-cancers-11-00295" class="usa-link" aria-describedby="B23-cancers-11-00295">23</a>,<a href="#B24-cancers-11-00295" class="usa-link" aria-describedby="B24-cancers-11-00295">24</a>,<a href="#B25-cancers-11-00295" class="usa-link" aria-describedby="B25-cancers-11-00295">25</a>,<a href="#B26-cancers-11-00295" class="usa-link" aria-describedby="B26-cancers-11-00295">26</a>,<a href="#B27-cancers-11-00295" class="usa-link" aria-describedby="B27-cancers-11-00295">27</a>,<a href="#B28-cancers-11-00295" class="usa-link" aria-describedby="B28-cancers-11-00295">28</a>,<a href="#B29-cancers-11-00295" class="usa-link" aria-describedby="B29-cancers-11-00295">29</a>,<a href="#B30-cancers-11-00295" class="usa-link" aria-describedby="B30-cancers-11-00295">30</a>,<a href="#B31-cancers-11-00295" class="usa-link" aria-describedby="B31-cancers-11-00295">31</a>,<a href="#B32-cancers-11-00295" class="usa-link" aria-describedby="B32-cancers-11-00295">32</a>,<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>,<a href="#B34-cancers-11-00295" class="usa-link" aria-describedby="B34-cancers-11-00295">34</a>,<a href="#B35-cancers-11-00295" class="usa-link" aria-describedby="B35-cancers-11-00295">35</a>,<a href="#B36-cancers-11-00295" class="usa-link" aria-describedby="B36-cancers-11-00295">36</a>].</p>
<p>In the present study, we investigated the splicing impact of ten <em>BRCA1/2</em> variants never before characterized in patient mRNA: four at the nearly invariant GT/AG dinucleotides at 5’ and 3’ intron ends (c.7618-2A&gt;G, c.7806-2A&gt;G, c.8331+1G&gt;A and c.8331+2T&gt;C in <em>BRCA2</em>), five in the adjacent less conserved splicing regions (c.302-5T&gt;C, c.441G&gt;C and c.441+5A&gt;G in <em>BRCA1</em>; c.68-5A&gt;G and c.476-3C&gt;A in <em>BRCA2</em>), and one outside the Cartegni consensus sequence (c.213-14C&gt;G in <em>BRCA1</em>). Real-time quantitative PCR (qPCR) was employed to evaluate the relative contribution of the different observed mRNA isoforms to the total transcript pool. A possible incomplete (“leaky”) spliceogenic effect was investigated using exonic tag single nucleotide polymorphisms (SNPs) or minigene assays, allowing the final assessment of pathogenicity according to the current guidelines of the ENIGMA consortium [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>].</p></section><section id="sec2-cancers-11-00295"><h2 class="pmc_sec_title">2. Results</h2>
<p>In the present study, we assessed the pathogenicity of ten unclassified variants in <em>BRCA1/2</em> identified in index cases selected from families undergoing genetic counseling and genetic testing. Nine variants were intronic (three in <em>BRCA1</em> and six in <em>BRCA2</em>) and one was located at the last nucleotide of <em>BRCA1</em> exon 7. By patient mRNA analysis, aberrant splicing patterns were demonstrated for eight variants (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a> and <a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a> and <a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>). Different types of abnormalities were observed: (1) alternative usage of canonical splice sites, including whole intron retention (c.441G&gt;C in <em>BRCA1</em>) (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>A) and whole exon skipping (c.476-3C&gt;A in <em>BRCA2</em>) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>A); (2) usage of de novo splice sites (c.68-5A&gt;G in <em>BRCA2</em>) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>B and <a href="#cancers-11-00295-f003" class="usa-link">Figure 3</a>A) and usage of cryptic splice sites (c.213-14C&gt;G in <em>BRCA1</em> and c.7618-2A&gt;G, c.7806-2A&gt;G, c.8331+1G&gt;A and c.8331+2T&gt;C in <em>BRCA2</em>) (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>B and <a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>C–E). In all cases, variant alleles produced transcripts leading to PTCs or in-frame deletions disrupting clinically important domains. Quantitative imbalances between physiological isoforms and aberrant transcripts were assessed by qPCR assays (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a> and <a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>). Complete/partial effect on splicing was established by the use of tag SNPs, whenever possible, or, alternatively, by monoallelic minigene assays, leading to variant classification according to current guidelines (<a href="#cancers-11-00295-f003" class="usa-link">Figure 3</a> and <a href="#cancers-11-00295-f004" class="usa-link">Figure 4</a>) [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. Consistent with in silico predictions, for two variants (c.302-5T&gt;C and c.441+5A&gt;G in <em>BRCA1</em>) a spliceogenic effect was not observed following patient mRNA analysis combined with methods preventing nonsense-mediated decay (NMD), or assessing allele-specific expression by tag-SNP analysis (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Figure S1</a>).</p>
<figure class="fig xbox font-sm" id="cancers-11-00295-f001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6468917_cancers-11-00295-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df2/6468917/ed164716bc7f/cancers-11-00295-g001.jpg" loading="lazy" height="563" width="766" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-11-00295-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA analysis of spliceogenic <em>BRCA1</em> variants. Amplified products were separated on 3% agarose gel and independently sequenced. Gel images, graphical representation, and exon–intron junction sequences of full-length (FL) and aberrant transcripts are shown in upper panels. Variants and RT-PCR primers locations are indicated by the arrows. qPCR results are shown as histograms displaying the relative expression of the full-length and aberrant transcript in the patient’s and controls’ samples (lower panels). (<strong>A</strong>) c.441G&gt;C, causing the retention of intron 7 (∇ivs7). The aberrant transcript accounts for 0.34 (±0.11) of overall gene expression in the variant carrier (case #1) and is undetectable in controls. (<strong>B</strong>) c.213-14G&gt;C, causing the retention of 59 nt at the 3′-end of intron 5 (∇59nt). The aberrant transcript accounts for 0.13 (±0.05) of overall gene expression in the variant carrier (case #4) and is undetectable in controls. M, molecular weight marker (0.15–2.1 Kbp, Roche); C, healthy control sample; NTC, no template control.</p></figcaption></figure><figure class="fig xbox font-sm" id="cancers-11-00295-f002"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6468917_cancers-11-00295-g002a.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df2/6468917/5774de1c2967/cancers-11-00295-g002a.jpg" loading="lazy" height="1017" width="791" alt="Figure 2"></a></p>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6468917_cancers-11-00295-g002b.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df2/6468917/dba6381a7d86/cancers-11-00295-g002b.jpg" loading="lazy" height="357" width="790" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-11-00295-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>mRNA analysis of spliceogenic <em>BRCA2</em> variants. Amplified products were separated on 3% agarose gel and independently sequenced. Gel images, graphical representation, and exon–intron junction sequences of full-length (FL) and aberrant transcripts are shown in upper panels. Variants and RT-PCR primers locations are indicated by the arrows. qPCR results are shown as histograms displaying the relative expression of the full-length and aberrant transcript in the patient’s and controls’ samples (lower panels). (<strong>A</strong>) c.476-3C&gt;A, causing the up-regulation of the isoforms lacking exon 6 (Δ6) and exons 5 and 6 (∆5,6). The Δ6 transcript accounts for 0.36 (±0.15) and Δ5,6 for 0.23 (±0.15) of overall gene expression in the variant carrier (case #2), and is nearly undetectable in controls. (<strong>B</strong>) c.68-5A&gt;G variant, causing the retention of four nucleotide at the 3’-end of intron 2 (∇4nt) and the up-regulation of the isoform lacking exon3 (∆3). The aberrant transcript, detectable exclusively in the variant case (case #3), accounts for 0.34 (±0.3) of overall gene expression. The ∆3 isoform accounts for 0.07 (±0.24) of overall gene expression in the variant carrier, 0.08 (±0.08) in the c.68-7T&gt;A sample, and 0.02 (±0.05) in controls. (<strong>C</strong>) c.7618-2A&gt;G variant, causing the deletion of 44 nt at the 5’-end of exon 16 (∆44nt). The aberrant transcript accounts for 0.10 (±0.24) of overall gene expression in the variant carrier (case #5) and is undetectable in controls. (<strong>D</strong>) c.7806-2A&gt;G, causing three different aberrant transcripts resulting from the deletion of 20 nt at the 5’end of exon 17 (Δ20nt), of 69 nt at the 5’end of exon 17 (Δ69nt) and of whole exon 17 (Δ17). Only the Δ20nt transcript is detectable in the variant carrier (case #6) and accounts for 0.11 (±0.06) of overall gene expression and is barely detected in control samples. (<strong>E</strong>) c.8331+1G&gt;A and c.8331+2T&gt;C variants, causing the deletion of 151 nt at the 3’-end of exon 17 and of the whole exon 18 (Δ151nt_ex17 + Δ18), and the up-regulation of the isoforms resulting from the deletion of exon 18 (Δ18) and of exons 17 and 18 (Δ17,18). The ∆151nt_ex17 + ∆18 transcript accounts for 0.09 (±0.001) and 0.04 (±0.06) of overall gene expression in c.8331+1G&gt;A (case #7) and c.8331+2T&gt;C (case #8) samples, respectively, and is undetectable in controls. The ∆18 transcript accounts for 0.23 (±0.2), 0.34 (± 0.09) and 0.03 (±0.21) of overall gene expression in case #7, case #8 and controls, respectively. The ∆17,18 transcript is undetectable in both variant cases and controls. M, molecular weight marker (0.15–2.1 Kbp, Roche and ΦX174 DNA/BsuRI (HaeIII) Marker, Thermo Scientific); C, healthy control sample; NTC, no template control.</p></figcaption></figure><section class="tw xbox font-sm" id="cancers-11-00295-t001"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>mRNA splicing effects of identified variants and predicted effect on protein.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant (Human Genome Variant Society, HGVS) Chromosome Position (GRCh37)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Classification (Entries) *</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Methods</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Observed Effect on Splicing</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect on mRNA (HGVS)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect on Protein (HGVS)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complete/Partial Effect (Method)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Splice Class †</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant Classification According to Published Guidelines <sup>§</sup>
</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<em>BRCA1</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.213-14C&gt;G<br>Chr17:g.41256987G&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS (2)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAXgene</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">retention of 59nt at 3′-end of intron 5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[212_213ins213-59_213-1; 213-14c &gt; g]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg71Serfs*11</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(minigene)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.302-5T&gt;C<br>Chr17:g.41256283A &gt; G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 6</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAXgene</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no effect</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 2</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.441G&gt;C<br>Chr17:g.41256139C&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exon 7</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP (1)/VUS (3)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAXgene</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">retention of intron 7</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[441_442ins441+1_442-1; 441g &gt; c]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Gln148Valfs*21</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(exonic tag SNP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.441 + 5A&gt;G<br>Chr17:g.41256134T&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 7</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAXgene</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">no effect</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 2</td>
</tr>
<tr>
<td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<em>BRCA2</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.68-5A&gt;G<br>Chr13:g.32893209A&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lymphocytes</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">retention of 4nt at 3′-end of intron 2;<br>up-regulation of ∆3 isoform</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[67_68ins68-4_68-1];<br>↑ r.[68_316del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.[Leu24Argfs*7];<br>↑ p.[Asp23_Leu105del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(minigene)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.476-3C&gt;A<br>Chr13:g.32900376C&gt;A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P (1)/VUS (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCL</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">up-regulation of ∆5,6 and ∆6 isoforms</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↑ r.[426_516del];<br>↑ r.[476_516del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">↑ p.[Ser142Argfs*13];<br>↑p.[Val159Glyfs*10];</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(exonic tag SNP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.7618-2A&gt;G<br>Chr13:g.32931877A&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 15</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P (1)/LP (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAXgene</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">skipping of 44nt at 5′-end of exon 16</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r. [7618_7661del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.[Leu2540Glnfs*11]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Complete<br>(minigene)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 5</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.7806-2A&gt;G<br>Chr13:g.32936658A&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 16</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P (8)/LP (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCL</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">skipping of 20nt at 5′-end of exon 17; skipping of 69nt at 5′-end of exon 17; skipping of exon 17</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[7806_7825del];<br> r.[7806_7874del];<br>r. [7806_7976del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.[Ala2603Cysfs*8]; <br>p.[Ala2603_Arg2625del];<br>p.[Ala2603Serfs*3]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Complete<br>(exonic tag SNP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class 5</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.8331 + 1G &gt; A<br>Chr13:g.32937671G&gt;A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 18</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P (3)/LP (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCL</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">skipping of 151nt at 3′-end of exon 17 and skipping of ex18; up-regulation of ∆ex17,18 and ∆ex18 isoforms</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[7826_8331del];<br>↑ r.[7806_8331del];<br>↑ r.[7977_8331del];</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.[Gly2609Aspfs*4];<br>↑ p.[Ala2603Phefs*43];<br>↑ p.[Tyr2660Phefs*43];</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(exonic tag SNP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.8331+2T&gt;C<br>Chr13:g.32937672T&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 18</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P (5)/LP (1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCL</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">skipping of 151nt at 3′-end of exon 17 and skipping of ex18; up-regulation of ∆ex17,18 and ∆ex18 isoforms</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r.[78268331del];<br>↑ r.[7806_8331del];<br>↑ r.[7977_8331del]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.[Gly2609Aspfs*4];<br>↑ p.[Ala2603Phefs*43];<br>↑ p.[Tyr2660Phefs*43];</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial<br>(exonic tag SNP)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cancers-11-00295-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p>* Clinvar (URL: <a href="https://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/</a>; last update 26 January 2019). VUS, variants of uncertain significance; LP, likely pathogenic; NP not provided; P, pathogenic; LCL, lymphoblastoid cell line; <sup>†</sup> Class 1S, no effect on splicing; Class 2S, leaky splice site variant: partial effect; Class 3S, severe impact on splicing: the mutant variant does not produce naturally occurring functional transcripts [<a href="#B19-cancers-11-00295" class="usa-link" aria-describedby="B19-cancers-11-00295">19</a>]. <sup>§</sup> Class 5, pathogenic; Class 4, likely pathogenic; Class 3, uncertain; Class 2, likely not pathogenic or of little clinical significance; <sup>§</sup> according to [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]; NA, not applicable. </p></div></div></section><figure class="fig xbox font-sm" id="cancers-11-00295-f003"><h3 class="obj_head">Figure 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6468917_cancers-11-00295-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df2/6468917/3ba724811cc0/cancers-11-00295-g003.jpg" loading="lazy" height="407" width="761" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-11-00295-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>RT-PCR analysis of the <em>BRCA1</em> and <em>BRCA2</em> minigene constructs expressed in HeLa cells using vector specific primers. A schematic representation of the hybrid minigene constructs is depicted on the left; the dotted lines indicate normal splicing. Each construct contains the exon close to, or harboring the variant of interest and part of the upstream and downstream introns of <em>BRCA1</em> or <em>BRCA2</em> genes. Electropherograms of the spliced transcripts are shown on the right. (<strong>A</strong>) The construct contains exon 3 of the <em>BRCA2</em> gene. c.68-5A&gt;G, construct containing the c.68-5A&gt;G variant. (<strong>B</strong>) The construct contains exon 6 of the <em>BRCA1</em> gene. c.213-14C&gt;G, construct containing the c.213-14C&gt;Gvariant. (<strong>C</strong>) The construct contains exon 16 of the <em>BRCA2</em> gene. c.7618-2A&gt;G, construct containing the c.7618-2A&gt;G variant. M, 1 kb plus molecular marker (Invitrogen); Empty, empty β-globin-pCDNA3.1 vector; WT, wild-type construct.</p></figcaption></figure><figure class="fig xbox font-sm" id="cancers-11-00295-f004"><h3 class="obj_head">Figure 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6468917_cancers-11-00295-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3df2/6468917/eaf19e7c5bc9/cancers-11-00295-g004.jpg" loading="lazy" height="1244" width="733" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-11-00295-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Determination of partial/total effect by SNP Sanger sequencing in the full-length (FL) transcripts from PAXgene samples (panel <strong>A</strong>) or LCLs (panels <strong>B</strong>–<strong>E</strong>). Primers are shown in <a href="#app1-cancers-11-00295" class="usa-link">Supplementary Table S3</a>. The arrows indicate the investigated SNPs.</p></figcaption></figure><section id="sec2dot1-cancers-11-00295"><h3 class="pmc_sec_title">2.1. Alternative Usage of Canonical Splicing Sites</h3>
<p>One variant in <em>BRCA1</em> (c.441G&gt;C), affecting the last nucleotide of exon 7, and for which conflicting interpretations of pathogenicity are reported in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), was predicted by two out of five in silico analyses to damage the donor splice site (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). Firstly, the hypothesis of exon 7 skipping was tested, but the detection of no alteration led us to postulate an intronic retention. The RT-PCR experiment for intronic retention showed the presence of an aberrant splicing product consisting of the whole intron 7 exonization, predicted to result in an early truncated protein lacking most functional domains (p.(Gln148Valfs*21)) (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>A). qPCR quantified a contribution of full-length and aberrant transcript to the total <em>BRCA1</em> expression of 66% and 34%, respectively. No intron 7-retaining transcript was found in controls (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>A). The use of the exonic variant itself (c.441G&gt;C) as tag-SNP analysis allowed for the determination of a partial splicing effect (<a href="#cancers-11-00295-f004" class="usa-link">Figure 4</a>A).</p>
<section class="tw xbox font-sm" id="cancers-11-00295-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>In silico analyses for variants leading to the usage of cryptic/de novo splice sites.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Variant</th>
<th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Location, SS, Distance</th>
<th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Canonical SS</th>
<th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Used Cryptic SS (Location, SS)</th>
<th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">De Novo SS</th>
</tr>
<tr>
<th colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Wt &gt; Mut (% Variation)</th>
<th colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Score</th>
<th colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Score</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MES</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SSF</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNSPLICE</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneSplicer</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSF</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MES</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SSF</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNSPLICE</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneSplicer</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSF</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MES</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SSF</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNSPLICE</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GeneSplicer</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSF</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gene:<em>BRCA1</em><br>c.213-14C&gt;G</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">intron 5, 3′, 14</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.213-59 (intron 5, 3′)</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.213-13 (intron 5, 3′)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.84 &gt; 2.23<br>(−53.9%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85.51 &gt; 83.10<br>(−2.8%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">=89.39</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.23</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.74</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.90</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.22</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.06</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.09</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.34</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.302-5T&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 6, 3′, 5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.7 &gt; 11.2<br>(−4.4%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.5 &gt; 88<br>(−3.9%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99 &gt; 0.98<br>(−0.7%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.4 &gt; 7.5<br>(−11%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.441G&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">exon 7, 5′, 1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.8 &gt; 67.8<br>(−14%)</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.441+5A&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 7, 5′, 5</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2 &gt; 8.8<br>(+173.7%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- &gt;82.0</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- &gt;1.0</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- &gt;2.9</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
</tr>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Gene:<em>BRCA2</em><br>c.68-5A&gt;G</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">intron 2, 3′, 5</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">6.10 &gt; 0.68<br>(−88.9%)</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">87.89&gt; -</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.94 &gt; 0.93<br>(−1.0%)</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NP</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">80.63 &gt; 80.56<br>(−0.1%)</td>
<td rowspan="2" colspan="5" align="center" valign="middle" style="border-bottom:solid thin">None</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.68-4 (intron 2, 3′)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.12</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.92</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.85</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.476-3C&gt;A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intron 5, 3′, 3</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.49 &gt; 6.02<br>(−42.6%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.73 &gt; 78.77<br>(−11.2%)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.91&gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.02&gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.61 &gt; 82.22<br>(−10.2%)</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">None</td>
</tr>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">c.7618-2A&gt;G</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">intron 15, 3′,</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.7662 (exon 16, 3′)</td>
<td rowspan="2" colspan="5" align="center" valign="middle" style="border-bottom:solid thin">NP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.11&gt;-</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.07 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.69 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.17 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.10 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.53</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73.60</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">c.7806-2A&gt;G</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">intron 16, 3′, 2</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">8.33 &gt; -</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">98.45 &gt; -</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.95 &gt; -</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">3.73 &gt; -</td>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">91.03 &gt; -</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.7826 (exon 17, 3′)</td>
<td rowspan="4" colspan="5" align="center" valign="middle" style="border-bottom:solid thin">NP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.95</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.60</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.97</td>
</tr>
<tr><td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.7875 (exon 17, 3′)</td></tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.03</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.60</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.54</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.95</td>
</tr>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">c.8331+1G&gt;A<br>c.8331+2T&gt;C</td>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Intron 18, 5′, 1<br>Intron 18, 5′, 2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.88 &gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.54&gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96&gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.27&gt; -</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.88&gt; -</td>
<td colspan="5" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">c.7826 * (exon 17, 5′)</td>
<td rowspan="2" colspan="5" align="center" valign="middle" style="border-bottom:solid thin">NP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.88&gt;</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.54 &gt; 87.12<br>(−0.5)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96&gt;</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.27&gt;</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.88&gt;</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.34</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.45</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.94</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NP</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.10</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cancers-11-00295-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>In silico analysis was performed using five prediction tools (Max Ent Scan, Splice Site Finder-like, NNSPLICE, GeneSplicer, Human Splicing Finder). -, SS abolished by the variant; NP, not predicted. Thresholds: MaxEnt, (0–12) for the 5′SS and (0–16) for the 3′SS, SSF (0–100), NNSPLICE (0–1), GeneSplicer (0–15), HSF (0–100). * This position is outside the range of prediction of Alamut Visual (199 bp), so data relative to this cryptic splice site were collected a posteriori, after the experimental analysis of the splicing pattern.</p></div></div></section><p>The c.476-3C&gt;A variant in <em>BRCA2</em>, occurring at the 3’ splice site of intron 5 and reported with conflicting interpretations of pathogenicity in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), was predicted to impair the canonical acceptor site by all bioinformatic tools (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). Analysis of patient’s RNA showed that the variant leads to the increase of two naturally occurring isoforms with different out-of-frame deletions: one lacking exon 6 (∆6) and the other lacking both exons 5 and 6 (∆5,6) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>A) [<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>]. Both transcripts result in early truncated proteins, defective of all functional domains. By qPCR all isoforms were quantified in patient sample and controls. Quantitative analysis showed that both alternative isoforms (∆6 and ∆5,6), barely detectable in controls, were highly expressed in patient sample, at levels comparable with the full-length transcript (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>A). Using an exonic tag SNP (c.1114A&gt;C; p.(Asn372His)), we demonstrated that canonical transcript mostly derives from wild-type allele but a very small peak corresponding to the SNP variant associated with the mutant allele was observed, indicating a minimal “leaky” effect (<a href="#cancers-11-00295-f004" class="usa-link">Figure 4</a>B).</p></section><section id="sec2dot2-cancers-11-00295"><h3 class="pmc_sec_title">2.2. Usage of A De Novo Splice Site</h3>
<p>The c.68-5A&gt;G substitution in <em>BRCA2</em>, reported as VUS in Clin Var, (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), reduces the strength of the canonical 3′ splice site in intron 2 and simultaneously generates an alternative acceptor splice site four nucleotides upstream, predicted by four out of five in silico tools (SSF, MES, NNSPLICE and HSF) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>B and <a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). The usage of this de novo splice site generates an isoform predicted to result in an early stop of translation with the consequently loss of all protein domains (p.(Leu24Argfs*7)) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>B). Simultaneously, the variant up-regulates the naturally occurring <em>BRCA2</em> isoform carrying the in-frame skipping of exon 3 (∆3) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>B). Expression quantification by qPCR revealed that the c.68-5A&gt;G variant induces an increase of ∆3 isoform (7% of the total transcript comparable to the one induced by the c.68-7T&gt;A variant found in another patient of our cohort (8% of the total transcript) vs. 2% in controls (mean value of ten samples) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>B). Minigene assay confirmed the generation of the out-of-frame isoform with the inclusion of four intronic nucleotides, but failed to detect the ∆3 isoform possibly due to the short sequence included in the construct that contains exon 3 and partial intronic flanking regions. The latter might not be enough to allow an alternative splicing mechanism. Sequencing of minigene product showed a very low level of full-length transcript produced from the mutated allele (<a href="#cancers-11-00295-f003" class="usa-link">Figure 3</a>A and <a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>).</p></section><section id="sec2dot3-cancers-11-00295"><h3 class="pmc_sec_title">2.3. Usage of Cryptic Splice Sites</h3>
<p>The c.213-14C&gt;G variant in <em>BRCA1</em>, reported as VUS in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), was predicted by all Alamut tools to activate a cryptic 3′ splice site at position c.213-59. In addition, three out of five interrogated tools (SSF, MES and HSF) predicted the creation of a de novo 3′ splice site at c.213-13 with a lower score respect to the cryptic site (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). In vitro analyses revealed an abnormal product consisting of the out-of-frame retention of 59 bases at the 3′ end of intron 5 (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>B). This partial intronic retention creates a premature stop codon with loss of all functional domains (p.(Arg71Serfs*11)). qPCR showed a low relative decrease of the full-length transcript in patient compared to control samples (87% vs. 100%) and that the aberrant product, totally absent in controls, contributed for 13% of the total <em>BRCA1</em> expression (<a href="#cancers-11-00295-f001" class="usa-link">Figure 1</a>B). Hybrid minigene assay displayed a partial spliceongenic effect (<a href="#cancers-11-00295-f003" class="usa-link">Figure 3</a>B). No effect due to the predicted creation of an alternative splice site at c.213-13 was observed.</p>
<p>The c.7618-2A&gt;G variant in <em>BRCA2</em>, reported as pathogenic or likely pathogenic in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), was predicted by all in silico tools to abolish the canonical 3′ splice site (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). By RT-PCR we demonstrated the skipping of 44 nt at the 5′-end of exon 16 due to the activation of an exonic cryptic acceptor site (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>C) predicted by only two (MES and HSF) out of five in silico tools (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). The predicted effect on the protein was the disruption of the DNA-binding domain (DBD) (p.(Leu2540Glnfs*11)). qPCR demonstrated a low contribution (10%) of the mutant transcript (∆44nt-ex16) to the total gene expression (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>C). Minigene assay confirmed the splicing pattern observed in patient’s mRNA and demonstrated a total spliceogenic effect (<a href="#cancers-11-00295-f003" class="usa-link">Figure 3</a>C).</p>
<p>The <em>BRCA2</em> c.7806-2A&gt;G variant, pathogenic or likely pathogenic in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>), was strongly predicted by all the in silico tools to abolish the natural acceptor splice site. In addition, the activation of two cryptic splice sites at positions c.7826 and c.7875 was predicted (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). The in vitro analysis confirmed a complex abnormal splicing pattern leading to the production of three different isoforms which include the whole deletion of exon 17 (∆17), and the partial deletion of either 20 or 69 nucleotides at the 5′-end of exon 17 (∆20nt-ex17 and ∆69nt-ex17) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>D). All alternative transcripts lead to the disruption of the DBD domain. The relative amount of each transcript on the total <em>BRCA2</em> expression was investigated by qPCR. The ∆20nt-ex17 transcript accounted for 10% of overall expression in the case sample and is quite absent in controls, while ∆69nt-ex17 was barely detected in the case and totally absent in controls. Quantification of ∆17 was not possible by qPCR, in both the case and controls, probably due to the very low expression levels. The analysis of the c.7397 tag SNP in exon 14, showing mono-allelic expression of the full-length transcript, proved a total spliceogenic effect of the variant considered (<a href="#cancers-11-00295-f004" class="usa-link">Figure 4</a>C).</p>
<p>The two alterations affecting the invariant dinucleotides at the 5′ end of intron 18 of <em>BRCA2</em>, c.8331+1G&gt;A and c.8331+2T&gt;C, were predicted by five and four in silico tools, respectively, to abolish the corresponding natural donor splice site (<a href="#cancers-11-00295-t002" class="usa-link">Table 2</a>). Both variants are classified as pathogenic or likely pathogenic in ClinVar (<a href="#cancers-11-00295-t001" class="usa-link">Table 1</a>). The in vitro characterization confirmed in both cases the same abnormal splicing pattern consisting in the skipping of the last 151 bp of exon 17 and of the whole exon 18 (∆151nt_ex17 + ∆18), in addition to the increase of the two naturally occurring isoforms involving exon 18 (∆18 and ∆17,18) (<a href="#cancers-11-00295-f002" class="usa-link">Figure 2</a>E) [<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>]. Quantification by qPCR of all detected transcripts revealed the relative decrease of the full length <em>BRCA2</em> mRNA in patient samples (67% for c.8331 + 1G &gt; A and 61% for c.8331+2T&gt;C vs. 96% in healthy control samples). The ∆18 isoform was found up-regulated in both samples (23% and 34% in c.8331+1G&gt;A and c.8331+2T&gt;C, respectively, vs. 3% in controls), while the lowly expressed ∆17,18 isoform could not be quantified both in samples and controls. The aberrant transcript lacking the last 151 bp of exon 17 and the entire exon 18, not expressed in controls, was shown to contribute for 9% and 4% of the total expression in c.8331+1G&gt;A and c.8331+2T&gt;C carriers, respectively. The analysis of the c.7242A&gt;G tag SNP in exon 14 demonstrated a bi-allelic expression of the full-length transcript in both cases (<a href="#cancers-11-00295-f004" class="usa-link">Figure 4</a>D,E).</p></section><section id="sec2dot4-cancers-11-00295"><h3 class="pmc_sec_title">2.4. No Splicing Effect</h3>
<p>For two variants in <em>BRCA1</em>, namely c.302-5T&gt;C and c.441+5A&gt;G, located in the 3′ and 5′ Cartegni consensus regions of intron 6 and intron 7, respectively, we did not detect any splicing aberration, as expected by the in silico prediction (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Figure S1</a>).</p>
<p>For the c.441+5A&gt;G, the use of an exonic tag SNP (c.4308T &gt; C) allowed to demonstrate biallelic expression (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Figure S1B</a>). No exonic tag SNPs were available for the c.302-5T&gt;C variant. Analysis of minigene expressed in cells treated with puromycin to prevent potential degradation of unstable transcripts via NMD [<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>], confirmed the presence of only the full-length transcript (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Figure S1A</a>).</p></section></section><section id="sec3-cancers-11-00295"><h2 class="pmc_sec_title">3. Discussion</h2>
<p><em>BRCA1</em> and <em>BRCA2</em> genetic test is fundamental for counseling and clinical management of high-risk breast-ovarian families. Massive parallel sequencing has greatly accelerated the analysis and the diagnostic process is generally straightforward for protein-truncating mutations. However, the interpretation of the biological consequences of the other types of variants still represents a challenge, creating problems in the clinical setting. Given that a significant fraction of VUS can have spliceogenic effects, transcript analysis represents an important tool to assess pathogenicity. Here, by patients′ mRNA analysis, we characterized the impact on splicing of ten <em>BRCA1/2</em> variants. For all these variants, multifactorial likelihood analysis was not applied due to the lack of sufficient data. Eight variants were demonstrated to impact on the normal splicing process and aberrant transcripts were characterized. Different types of abnormal splicing events were observed, including intron retention (c.441G&gt;Cin <em>BRCA1</em>), exon skipping (c.476-3C&gt;A in <em>BRCA2</em>), and alternative 5′ or 3′ splice site activation (c.213-14C&gt;G in <em>BRCA1</em> and c.68-5A&gt;G, c.7618-2A&gt;G, c.7806-2A&gt;G c.8331+1G&gt;A, c.8331+2T&gt;C in <em>BRCA2</em>), leading to transcripts with PTCs or in-frame loss of functionally important residues. Partial/complete splicing impact and quantitative contribution of different transcripts were assessed leading to variants classification according to current guidelines developed by the ENIGMA consortium [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>].</p>
<p>We demonstrated that the c.441G&gt;C variant in <em>BRCA1</em> causes the retention of intron 7. In the absence of in vitro studies assessing allele-specific transcript expression, this variant, causing G &gt; non-G substitution at the last base of the exon and with the first 6 bases of the intron not being GTRRGT, would have been considered of Class 4 (likely pathogenic) [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. In the present study, the usage of the variant itself as a tag-SNP allowed to reveal a partial splicing effect, leading to a Class 3 (VUS) reassignment, in accordance with ENIGMA guidelines [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. As to the c.476-3C&gt;A variant in <em>BRCA2</em>, we observed the up-regulation of transcripts carrying the out-of-frame deletions of exon 6 (∆6) and exons 5–6 (Δ5–6). Both isoforms were barely detectable in control samples, in accordance with previous studies reporting these exon-skipping events as naturally occurring at low expression levels [<a href="#B21-cancers-11-00295" class="usa-link" aria-describedby="B21-cancers-11-00295">21</a>,<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>,<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>]. Up-regulation of these non-functional products had been previously reported in association with the c.476-2A&gt;G, c.516G&gt;A and c.516+1G&gt;T pathogenic <em>BRCA2</em> variants [<a href="#B28-cancers-11-00295" class="usa-link" aria-describedby="B28-cancers-11-00295">28</a>,<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>,<a href="#B39-cancers-11-00295" class="usa-link" aria-describedby="B39-cancers-11-00295">39</a>]. By real-time qPCR, we demonstrated that the c.476-3C&gt;A variant causes the up-regulation of both alternative isoforms at a level comparable with that of the full-length transcript. Since a minimal “leaky” effect was demonstrated by the use of an exonic tag SNP, current guidelines indicate to consider the variant of Class 3 and recommend multifactorial likelihood analysis to assess a definitive pathogenic role [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>].</p>
<p>Concerning the activation of alternative splice sites, we found that the c.68-5A&gt;G variant in <em>BRCA2</em>, creating a de novo acceptor splice site four nucleotides upstream exon 3, leads to the production of an out-of-frame transcript predicted to result in an early interruption of translation (p.(Leu24Argfs*7)). Simultaneously, we observed an up-regulation of a naturally occurring <em>BRCA2</em> isoform carrying the in-frame skipping of exon 3 (∆3). In accordance with previous data [<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>,<a href="#B39-cancers-11-00295" class="usa-link" aria-describedby="B39-cancers-11-00295">39</a>,<a href="#B40-cancers-11-00295" class="usa-link" aria-describedby="B40-cancers-11-00295">40</a>], the ∆3 isoform was present in our control samples, representing a non-negligible fraction of the total transcript. The extent of up-regulation of the ∆3 isoform in the presence of the c.68-5A &gt; G variant (approximately 7%) was comparable with that found in one patient carrying the already reported c.68-7T&gt;A <em>BRCA2</em> variant (approximately 8%). The c.68-7T&gt;A substitution has been the object of intense debate concerning its pathogenetic role [<a href="#B14-cancers-11-00295" class="usa-link" aria-describedby="B14-cancers-11-00295">14</a>,<a href="#B19-cancers-11-00295" class="usa-link" aria-describedby="B19-cancers-11-00295">19</a>,<a href="#B27-cancers-11-00295" class="usa-link" aria-describedby="B27-cancers-11-00295">27</a>,<a href="#B40-cancers-11-00295" class="usa-link" aria-describedby="B40-cancers-11-00295">40</a>,<a href="#B41-cancers-11-00295" class="usa-link" aria-describedby="B41-cancers-11-00295">41</a>], but a recent article finally classified it as benign [<a href="#B42-cancers-11-00295" class="usa-link" aria-describedby="B42-cancers-11-00295">42</a>]. The c.68-5A&gt;G variant here identified, with respect to the c.68-7T&gt;A substitution, generated an additional transcript containing an early PTC. The up-regulation of the in-frame alternative ∆3 isoform may raise concerns about the clinical impact of the variant. However, exclusive expression of the ∆3-transcript from one allele has been demonstrated to be associated with a high risk of breast and/or ovarian cancer [<a href="#B40-cancers-11-00295" class="usa-link" aria-describedby="B40-cancers-11-00295">40</a>,<a href="#B41-cancers-11-00295" class="usa-link" aria-describedby="B41-cancers-11-00295">41</a>]. In fact, residues encoded by exon 3 have been demonstrated to be important for the interaction with PALB2, a cofactor essential for the nuclear localization of the BRCA2 protein, the interaction with BRCA1, the recruitment of RAD51 to the DNA double strand breaks (DSBs), and the protection of the replication forks. In fact, the disruption of the interaction between PALB2 and BRCA2 has been demonstrated to impair the DNA DSBs repair function [<a href="#B41-cancers-11-00295" class="usa-link" aria-describedby="B41-cancers-11-00295">41</a>,<a href="#B43-cancers-11-00295" class="usa-link" aria-describedby="B43-cancers-11-00295">43</a>,<a href="#B44-cancers-11-00295" class="usa-link" aria-describedby="B44-cancers-11-00295">44</a>,<a href="#B45-cancers-11-00295" class="usa-link" aria-describedby="B45-cancers-11-00295">45</a>,<a href="#B46-cancers-11-00295" class="usa-link" aria-describedby="B46-cancers-11-00295">46</a>]. Moreover, the results from multifactorial likelihood analysis of six <em>BRCA2</em> variants leading to full exon 3 skipping strongly inclines in favor of a pathogenic role of these variants [<a href="#B41-cancers-11-00295" class="usa-link" aria-describedby="B41-cancers-11-00295">41</a>]. Notwithstanding, minigene analysis revealed the expression the of full-length transcript from the mutated allele, although at very low level, which, formally does not allow to classify the c.68-5A &gt; G variant as pathogenic, in the absence of additional evidences.</p>
<p>Activation of cryptic splice sites was demonstrated for the remaining five spliceogenic variants (c.213-14C&gt;G in <em>BRCA1</em> and c.7618-2A&gt;G c.7806-2A&gt;G c.8331+1G&gt;A, c.8331+2T&gt;C in <em>BRCA2</em>). The c.213-14C&gt;G variant in <em>BRCA1</em> was predicted to weaken canonical splicing and to activate a cryptic 3′ splice site. Patient mRNA analysis confirmed the prediction and showed the out-of-frame retention of 59 bp at the 3′ end of intron 5. The usage of the same cryptic acceptor site had been previously reported for the c.213-11T&gt;G pathogenic variant, suggesting that this site is preferentially used when the canonical one is weakened or eliminated [<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>]. The exonization of this part of intron 5 is associated with a very low expression level of the resulting transcript, compared to full-length, as shown by quantitative expression analysis. This is consistent with the evidence of the partial splicing effect detected by minigene assay and supports the classification of the variant as Class 3 [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. The c.7618-2A&gt;G variant in <em>BRCA2</em>, predicted by all in silico tools to abolish the canonical 3′ splice site, showed an aberrant out-of-frame transcript devoid of the first 44 nt of exon 16, due to the activation of a cryptic exonic splice site predicted by only two out of five prediction tools (MES and HSF). The contribution of the aberrant transcript to the total gene expression was very low (approximately 10%) suggesting a possible role of NMD in triggering the degradation of the mutant transcript in patient’s cell lines. However, this possibility was not experimentally verified by puromycin treatment. The same aberration had been previously demonstrated for the adjacent c.7618-1G&gt;A pathogenic variant [<a href="#B28-cancers-11-00295" class="usa-link" aria-describedby="B28-cancers-11-00295">28</a>]. Since no informative (heterozygous) <em>BRCA2</em> exonic SNPs were present in carrier of the c.7618-2A&gt;G, allele-specific expression was assessed by minigene assay, which represents a valuable tool to guide clinical classification of spliceogenic variant in cases where tag-SNP analyses cannot be performed. The assay showed the production of only the mutant transcript, allowing the classification of the variant as pathogenic. The c.7806-2A&gt;G variant in <em>BRCA2</em>, predicted by all the in silico tools to abolish the canonical 3′ splice site, in addition to the skipping of exon 17, leads to the activation of two exonic cryptic splice sites, producing two transcripts lacking respectively 20 and 69 nt at the 5′-end of exon 17. All the produced mRNAs carry a PTC leading to the loss of the DBD. Noticeably, in a previous investigation of the variant, only the transcript missing 20 nt was observed, whereas the two transcripts lacking the entire exon 17 and the 69 nt at the 5′-end of the exon were not detected [<a href="#B19-cancers-11-00295" class="usa-link" aria-describedby="B19-cancers-11-00295">19</a>]. The ratio of the total amount of the aberrant transcripts, taken together, to the total <em>BRCA2</em> expression was very low (~10%). Given the exclusion of a leaky effect of the mutation by tag-SNP analysis, we can hypothesize a massive degradation of the aberrant transcripts possibly induced by the formation of PTCs. However, also for this sample puromycin treatment was not performed. These findings, obtained by a direct patient’s mRNA analysis, are concordant with the data obtained with the minigene assay by Fraile-Bethencourt et al. [<a href="#B36-cancers-11-00295" class="usa-link" aria-describedby="B36-cancers-11-00295">36</a>], and contribute to the final classification of the described variant as pathogenic, given that no full-length transcript was found to be produced by the mutated allele. The two variants c.8331+1G&gt;A and c.8331+2T&gt;C, both predicted to abolish the canonical exon 18 donor splice site, generate three mis-spliced transcripts, each carrying a PTC. Two of these transcripts (∆18 and ∆17,18) are reported as naturally occurring variants, found in normal samples at low levels [<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>]. Quantitative analysis showed a relative increase of ∆18 isoform in cases respect to controls, while neither in cases nor in controls the amount of the ∆17,18 isoform was detected by qPCR, probably due to technique limitations. The third transcript, showing the loss of 151 bp at exon 17 3′-end and of exon 18 (∆151nt_ex17 + ∆18), was generated by the usage of an exonic cryptic splice site, probably activated following the loss of the canonical donor site of exon 18. This transcript is exclusively expressed in cases and its contribution to the overall <em>BRCA2</em> expression is higher in the c.8331+1G&gt;A carrier (9%) than in the c.8331+2T&gt;C carrier (4%). The alternative transcripts overall contribute to the total <em>BRCA2</em> expression for 32% and 38% in c.8331+1G&gt;A and c.8331+2T&gt;C, respectively. These two variants affect the same splice site of the c.8331+1G&gt;T, previously reported to induce aberrant splicing and classified as pathogenic by Fraile-Bethencourt et al. [<a href="#B36-cancers-11-00295" class="usa-link" aria-describedby="B36-cancers-11-00295">36</a>]. In the same study, these authors classified as pathogenic also the c.8331+2T&gt;C, based on the observation, by minigene assay, of no full-length expression by the mutated allele. By contrast, in our study, tag-SNP analysis revealed the expression of the normal transcript from both the wild-type and the mutated allele. While this discrepancy could be attributed to the different approaches used in the two studies to assess allele-specific expression, our results argue against a classification of the c.8331+2T&gt;C as pathogenic (Class 5). The same applies also to the c.8331+1G&gt;A, which in our hands displays a bi-allelic full-length expression. Therefore, in our opinion, in the absence of further evidences, both the above variants should be classified at present as “uncertain” (Class 3), according to the ENIGMA guidelines [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>].</p>
<p>This study allowed the assessed for the first time the complete aberrant splicing effect in patients’ mRNA for the c.7618-2A&gt;G and c.7806-2A&gt;G <em>BRCA2</em> variants, providing strong evidence of their pathogenicity. These findings have important consequences for families in terms of preventive and prophylactic measures, as well as targeted therapies such as those based on the use of PARP-inhibitors. In accordance with in silico prediction, we demonstrated that the c.441+5A&gt;G and c.302-5T&gt;C variants in <em>BRCA1</em> have no splicing impact, allowing a final classification as likely benign [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. Finally, due to evidences of a partial splicing effect, six variants (c.213-14C&gt;G, c.441G&gt;C in <em>BRCA1</em> and c.68-5A&gt;G, c.476-3C&gt;A, 8331+1G&gt;A and 8331+2T&gt;C in <em>BRCA2</em>) remain of Class 3 in accordance with current interpretation guidelines [<a href="#B37-cancers-11-00295" class="usa-link" aria-describedby="B37-cancers-11-00295">37</a>]. This conservative criterion is justified considering that spliceogenic variants preserving the ability to synthesize a normal (full-length) transcript do not completely abrogate the synthesis of a normal protein and might maintain a tumor suppressor activity [<a href="#B25-cancers-11-00295" class="usa-link" aria-describedby="B25-cancers-11-00295">25</a>]. At least in some instances, these alterations might be associated with a lower tumor risk, compared to classical pathogenic BRCA gene variants. This justifies caution in patients’ management although, if present in patients with ovarian cancer, they could anyhow be targeted by PARP inhibitors, in view of the potential beneficial effect of such therapy.</p></section><section id="sec4-cancers-11-00295"><h2 class="pmc_sec_title">4. Patients and Methods</h2>
<section id="sec4dot1-cancers-11-00295"><h3 class="pmc_sec_title">4.1. Patients</h3>
<p>Patients were selected among those who attended three different Italian centers (Azienda Ospedaliera Universitaria Senese, Fondazione IRCCS, Istituto Nazionale dei Tumori (INT) of Milan, Azienda Ospedaliero-Universitaria di Modena) for genetic counseling and <em>BRCA1/BRCA2</em> testing. Genetic analysis was offered based on individual and/or family history according to updated National Comprehensive Cancer Network (NCCN) guidelines (NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian) or local inclusion criteria [<a href="#B47-cancers-11-00295" class="usa-link" aria-describedby="B47-cancers-11-00295">47</a>]. Sporadic cases of OC accessed to the molecular analysis on the basis of national recommendations [<a href="#B48-cancers-11-00295" class="usa-link" aria-describedby="B48-cancers-11-00295">48</a>]. After a first DNA-level analysis performed by massive parallel sequencing (Ion Torrent PGM, Life Technologies, Carlsbad, CA, USA), or conventional Sanger sequencing, patients with VUS that could potentially alter the mRNA splicing process were selected for in vitro studies. The significance and consequences of VUS identification were discussed with patients in post-test counseling. New blood samples were thus collected in order to investigate the pathogenicity of the variants by transcript analysis. Informed consent was obtained prior to testing and the study was approved 28 January 2015 by the local Ethics Committee of the Istituto Nazionale Tumori (INT); ethic code: N. INT 7/15.</p></section><section id="sec4dot2-cancers-11-00295"><h3 class="pmc_sec_title">4.2. Methods</h3>
<section id="sec4dot2dot1-cancers-11-00295"><h4 class="pmc_sec_title">4.2.1. In Silico Splicing Analysis</h4>
<p>Five tools integrated in the Alamut Visual software application (Interactive Biosoftware, Version 2.7, Rouen, France) were used for in silico prediction of the impact on the splicing process: Splice Site Finder-like (SSF), MaxEntScan (MES) Splice Site Prediction by Neural Network (NNSPLICE) GeneSplicer (GS) and Human Splicing Finder (HSF) [<a href="#B16-cancers-11-00295" class="usa-link" aria-describedby="B16-cancers-11-00295">16</a>,<a href="#B49-cancers-11-00295" class="usa-link" aria-describedby="B49-cancers-11-00295">49</a>,<a href="#B50-cancers-11-00295" class="usa-link" aria-describedby="B50-cancers-11-00295">50</a>,<a href="#B51-cancers-11-00295" class="usa-link" aria-describedby="B51-cancers-11-00295">51</a>,<a href="#B52-cancers-11-00295" class="usa-link" aria-describedby="B52-cancers-11-00295">52</a>,<a href="#B53-cancers-11-00295" class="usa-link" aria-describedby="B53-cancers-11-00295">53</a>].</p></section><section id="sec4dot2dot2-cancers-11-00295"><h4 class="pmc_sec_title">4.2.2. Cell Cultures</h4>
<p>Mononuclear cells were isolated from 5 mL of peripheral blood supplemented with Ficoll. Epstein-Barr virus (EBV)-immortalized human lymphoblastoid cell lines (LCLs) were established and grown as previously reported [<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>].</p></section><section id="sec4dot2dot3-cancers-11-00295"><h4 class="pmc_sec_title">4.2.3. RNA Extraction and Reverse Transcriptase-PCR (RT-PCR)</h4>
<p>Depending on the strategies used in the participating laboratories, different protocols of RNA extraction from blood were used. Total RNA was isolated from PAXgene blood RNA tubes (PreAnalytiX®, Qiagen, Hilden, Germany) (http:/www.qiagen.com), with PAXgene Blood RNA Kit (IVD) (PreAnalytiX®), following the manufacturer’s instructions and quantified by NanoDrop 2000 Spectrophotometer (Thermo Scientific). For each sample, 1 µg of RNA was reverse-transcribed into cDNA using a dedicated Qiagen kit (QuantiTect® Reverse Transcription Kit, Qiagen) according to the manufacturer’s instructions. RNA from LCLs was extracted and reversed transcribed as described [<a href="#B42-cancers-11-00295" class="usa-link" aria-describedby="B42-cancers-11-00295">42</a>]. cDNA was stored at −20 °C until use.</p></section><section id="sec4dot2dot4-cancers-11-00295"><h4 class="pmc_sec_title">4.2.4. Transcript Characterization</h4>
<p>In order to verify the effect of considered VUS on BRCA gene splicing, specific PCR primers were designed (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Table S1</a>). For each amplification, a free-cDNA sample and five normal control cDNA samples were included. PCRs were performed using GoTaq DNA Polymerase reagents (5× GoTaq Flexi buffer; 25 mM MgCl<sub>2</sub>, GoTaq Hot Start Polymerase), in addition with 2 mM dNTPS, milliQ H<sub>2</sub>O and 100 ng of cDNA, for a final volume of 50 µL. Amplification was performed in a Thermal Cycler 2720 (Applied Biosystem, Foster City, CA, USA) with the following PCR program: 95 °C for 5 min; 35 cycles at 95 °C for 30 s, at the specific annealing temperature for 30 s, at 72 °C for 60 s; 72 °C for 5 min. Then, 10 µL of amplified PCR products were mixed with the loading dye, containing Bromophenol Blue, and separated by electrophoresis on a 3% agarose gel. Bands were displayed in an UV transilluminator. In all cases in which it was possible to discriminate different gel bands, the different amplification products were purified using the Zyomoclean Gel DNA Recovery kit (Zymo research, Irvine, CA-USA). In the remaining cases, unfractionated PCR products were purified and cloned as previously described [<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>]. Each cDNA PCR products were sequenced using PE Big dye terminator cycle sequencing kit on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems). The software Sequencer (v.4.9) was used for sequence analysis.</p></section><section id="sec4dot2dot5-cancers-11-00295"><h4 class="pmc_sec_title">4.2.5. WT/Mutant Transcript Quantification by Quantitative Polymerase Chain Reaction (qPCR)</h4>
<p>To quantify the relative expression levels of transcripts in mutant and control samples, quantitative polymerase chain reaction (qPCR) with isoforms-specific primers (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Table S2</a>) was performed. A region not involved in splicing aberrations, and not subject to naturally occurring alternative splicing [<a href="#B38-cancers-11-00295" class="usa-link" aria-describedby="B38-cancers-11-00295">38</a>,<a href="#B54-cancers-11-00295" class="usa-link" aria-describedby="B54-cancers-11-00295">54</a>], was selected as internal control to take into account the inter-individual variability of <em>BRCA1</em>/<em>2</em> expression. <em>GUSB</em> was used as housekeeping gene to normalize cDNA amounts [<a href="#B42-cancers-11-00295" class="usa-link" aria-describedby="B42-cancers-11-00295">42</a>]. For controls the average value of ten samples was considered. Quantitative PCR was carried out in single-plex reactions in a 96-well optical plate with FastStart SYBR Green Master Mix (Roche) on the ABI Prism 7000 Sequence Detection System (Applied Biosystems). Experiments were performed in triplicate in a final volume of 20 µL with 25 ng of cDNA and 25 nM of each primer, following the SYBR Green protocol (Roche, Basel, Switzerland). Standard thermal cycling conditions were: 2 min at 50 °C and 10 min at 95 °C; 40 cycles at 95 °C for 15 s and 60 °C for 1 min; dissociation stage 95 °C for 15 s, 60 °C for 20 s and 95 °C for 15 s. The mean value of each triplicate was firstly normalized to the housekeeping gene (∆Ct). The ∆Ct of the full-length and aberrant transcripts was then normalized to that of the internal control (∆∆Ct), applying the comparative Ct method to obtain the relative expression quantification [<a href="#B55-cancers-11-00295" class="usa-link" aria-describedby="B55-cancers-11-00295">55</a>]. In each sample, the expression levels of all observed fragments were expressed as a percentage of the total expression of all fragments, i.e., analyzed transcript/(full-length + alternative transcripts).</p></section><section id="sec4dot2dot6-cancers-11-00295"><h4 class="pmc_sec_title">4.2.6. Assessment of Partial/Total Effect on Splicing by the Use of Exonic Tag SNPs</h4>
<p>Whenever possible informative exonic SNPs were analyzed to assess a total or partial effect on splicing of investigated intronic variants. For each variant a PCR fragment spanning the exonic tag-SNP was amplified from the canonical (full-length) transcript by the use of specific primers (<a href="#app1-cancers-11-00295" class="usa-link">Supplementary Table S3</a>) and sequenced to assess mono or biallelic expression.</p></section><section id="sec4dot2dot7-cancers-11-00295"><h4 class="pmc_sec_title">4.2.7. In Vivo Splicing Assay with Minigenes</h4>
<p>A portion of the gene containing the exon close to or harboring each variant of interest and part of the flanking introns was amplified from patients’ genomic DNA (oligonucleotides and PCR conditions are available upon request). PCR fragments were subsequently cloned into the β-globin-pCDNA3.1 vector to produce the hybrid minigene constructs, as previously described [<a href="#B56-cancers-11-00295" class="usa-link" aria-describedby="B56-cancers-11-00295">56</a>,<a href="#B57-cancers-11-00295" class="usa-link" aria-describedby="B57-cancers-11-00295">57</a>]. The mutant minigene constructs, their corresponding wild-type versions or the empty vector were transfected into HeLa cells and after 24 hours total RNA was extracted using the TRIzol kit (Invitrogen) and reverse transcribed. The cDNA was then amplified using primers located on β-globin exons 2 and 3 and PCR fragments were separately sequenced as previously reported [<a href="#B57-cancers-11-00295" class="usa-link" aria-describedby="B57-cancers-11-00295">57</a>]. Puromycin treatment of cell line transfected with the minigene carrying the <em>BRCA1</em> c.302-5T &gt; C variant was performed as described [<a href="#B33-cancers-11-00295" class="usa-link" aria-describedby="B33-cancers-11-00295">33</a>].</p></section></section></section><section id="sec5-cancers-11-00295"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>Our results provide further evidence of the usefulness of mRNA analysis for the clinical classification of variants in disease-associated genes. In fact, through this approach we were able to provide evidence assessing two <em>BRCA2</em> variants (c.7618-2A&gt;G and c.7806-2A&gt;G) as pathogenic and two <em>BRCA1</em> variants (c.302-5T&gt;C and c.441+5A&gt;G) as benign. However, we also observed that a large fraction (<em>n</em> = 6) of investigated spliceogenic variants retain the ability to produce (although at variable levels) functional full-length transcripts, and therefore, cannot be definitively classified as pathogenic according to current guidelines.</p>
<p>Due the availability of specific risk-reduction measures and new therapeutic approaches for carriers of pathogenic BRCA gene variants, the development of ad hoc strategies for the classification of variants with a partial splicing effect has become an urgent need. Along this line, two recent studies of the ENIGMA consortium, combining genetic and clinical data analysis with accurate mRNA isoform quantification, were able to demonstrate the non-pathogenicity of the <em>BRCA1</em> c.[594-2A&gt;C; 641A&gt;G] and <em>BRCA2</em> c.68-7T&gt;A leaky splicing variants [<a href="#B42-cancers-11-00295" class="usa-link" aria-describedby="B42-cancers-11-00295">42</a>,<a href="#B58-cancers-11-00295" class="usa-link" aria-describedby="B58-cancers-11-00295">58</a>]. In both cases, these investigations defined the threshold for ratio between altered and functionally proficient gene transcripts not associated with high cancer risk. These observations could inform the classification of other BRCA gene variants causing partial spliceogenic effects, thus improving the informativeness of BRCA testing and the number of families and individuals that can benefit from such tests.</p></section><section id="app1-cancers-11-00295" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online at <a href="https://www.mdpi.com/2072-6694/11/3/295/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/2072-6694/11/3/295/s1</a>, Figure S1: mRNA analysis of non-spliceogenic <em>BRCA1</em> variants from PAXgene samples, Table S1: Primers for mRNA splicing, Table S2: Primers used in Real-time qPCR, Table S3: Primers used for Tag-SNPs sequencing.</p>
<section class="sm xbox font-sm" id="cancers-11-00295-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/6468917/bin/cancers-11-00295-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (2.1MB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>E.G. and M.C. performed the experiments and drafted the manuscript; P.R., A.R. and F.A. made substantial contributions to conception and design of the study and reviewed the manuscript; A.M.P. made important contributions in interpretation of molecular results and clinical data collection; S.A., E.F., V.I., L.C. (Lorenza Catania), G.D.V., C.F., E.T. (Enrico Tagliafico), V.M. and E.T. (Eva Trevisson) contributed to the experiments and data acquisition; M.B., C.L.R., M.A.M., L.C. (Laura Cortesi), F.S. and S.M. conducted the genetic counseling of the patients. All authors have given the approval of the final version of the manuscript to be published. They ensure that all aspects of the work are investigated and resolved with accuracy and integrity.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Funds from Italian citizens who allocated the 5 × 1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects ‘5 × 1000’) to S. Manoukian. Associazione Italiana Ricerca sul Cancro (AIRC; IG2014 no.15547) to P. Radice.</p></section><section id="notes3"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-cancers-11-00295">
<span class="label">1.</span><cite>Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007;18:581–592. doi: 10.1093/annonc/mdl498.</cite> [<a href="https://doi.org/10.1093/annonc/mdl498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17287242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Estimates%20of%20the%20cancer%20incidence%20and%20mortality%20in%20Europe%20in%202006&amp;author=J.%20Ferlay&amp;author=P.%20Autier&amp;author=M.%20Boniol&amp;author=M.%20Heanue&amp;author=M.%20Colombet&amp;volume=18&amp;publication_year=2007&amp;pages=581-592&amp;pmid=17287242&amp;doi=10.1093/annonc/mdl498&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-cancers-11-00295">
<span class="label">2.</span><cite>Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010;127:2893–2917. doi: 10.1002/ijc.25516.</cite> [<a href="https://doi.org/10.1002/ijc.25516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21351269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Estimates%20of%20worldwide%20burden%20of%20cancer%20in%202008:%20GLOBOCAN%202008&amp;author=J.%20Ferlay&amp;author=H.-R.%20Shin&amp;author=F.%20Bray&amp;author=D.%20Forman&amp;author=C.%20Mathers&amp;volume=127&amp;publication_year=2010&amp;pages=2893-2917&amp;pmid=21351269&amp;doi=10.1002/ijc.25516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-cancers-11-00295">
<span class="label">3.</span><cite>Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 2016;66:7–30. doi: 10.3322/caac.21332.</cite> [<a href="https://doi.org/10.3322/caac.21332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26742998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&amp;title=Cancer%20statistics,%202016&amp;author=R.L.%20Siegel&amp;author=K.D.%20Miller&amp;author=A.%20Jemal&amp;volume=66&amp;publication_year=2016&amp;pages=7-30&amp;pmid=26742998&amp;doi=10.3322/caac.21332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-cancers-11-00295">
<span class="label">4.</span><cite>Newman B., Austin M.A., Lee M., King M.C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. USA. 1988;85:3044–3048. doi: 10.1073/pnas.85.9.3044.</cite> [<a href="https://doi.org/10.1073/pnas.85.9.3044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC280139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3362861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Inheritance%20of%20human%20breast%20cancer:%20evidence%20for%20autosomal%20dominant%20transmission%20in%20high-risk%20families&amp;author=B.%20Newman&amp;author=M.A.%20Austin&amp;author=M.%20Lee&amp;author=M.C.%20King&amp;volume=85&amp;publication_year=1988&amp;pages=3044-3048&amp;pmid=3362861&amp;doi=10.1073/pnas.85.9.3044&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-cancers-11-00295">
<span class="label">5.</span><cite>Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B., King M.C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684–1689. doi: 10.1126/science.2270482.</cite> [<a href="https://doi.org/10.1126/science.2270482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2270482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Linkage%20of%20early-onset%20familial%20breast%20cancer%20to%20chromosome%2017q21&amp;author=J.M.%20Hall&amp;author=M.K.%20Lee&amp;author=B.%20Newman&amp;author=J.E.%20Morrow&amp;author=L.A.%20Anderson&amp;volume=250&amp;publication_year=1990&amp;pages=1684-1689&amp;pmid=2270482&amp;doi=10.1126/science.2270482&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-cancers-11-00295">
<span class="label">6.</span><cite>Claus E.B., Risch N., Thompson W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 1991;48:232–242.</cite> [<a href="/articles/PMC1683001/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1990835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Genetic%20analysis%20of%20breast%20cancer%20in%20the%20cancer%20and%20steroid%20hormone%20study&amp;author=E.B.%20Claus&amp;author=N.%20Risch&amp;author=W.D.%20Thompson&amp;volume=48&amp;publication_year=1991&amp;pages=232-242&amp;pmid=1990835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-cancers-11-00295">
<span class="label">7.</span><cite>Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71. doi: 10.1126/science.7545954.</cite> [<a href="https://doi.org/10.1126/science.7545954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7545954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A%20strong%20candidate%20for%20the%20breast%20and%20ovarian%20cancer%20susceptibility%20gene%20BRCA1&amp;author=Y.%20Miki&amp;author=J.%20Swensen&amp;author=D.%20Shattuck-Eidens&amp;author=P.A.%20Futreal&amp;author=K.%20Harshman&amp;volume=266&amp;publication_year=1994&amp;pages=66-71&amp;pmid=7545954&amp;doi=10.1126/science.7545954&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-cancers-11-00295">
<span class="label">8.</span><cite>Kuchenbaecker K.B., Hopper J.L., Barnes D.R., Phillips K.-A., Mooij T.M., Roos-Blom M.-J., Jervis S., van Leeuwen F.E., Milne R.L., Andrieu N., et al.  Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317:2402–2416. doi: 10.1001/jama.2017.7112.</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Risks%20of%20Breast,%20Ovarian,%20and%20Contralateral%20Breast%20Cancer%20for%20BRCA1%20and%20BRCA2%20Mutation%20Carriers&amp;author=K.B.%20Kuchenbaecker&amp;author=J.L.%20Hopper&amp;author=D.R.%20Barnes&amp;author=K.-A.%20Phillips&amp;author=T.M.%20Mooij&amp;volume=317&amp;publication_year=2017&amp;pages=2402-2416&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-cancers-11-00295">
<span class="label">9.</span><cite>Moran A., O’Hara C., Khan S., Shack L., Woodward E., Maher E.R., Lalloo F., Evans D.G.R. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam. Cancer. 2012;11:235–242. doi: 10.1007/s10689-011-9506-2.</cite> [<a href="https://doi.org/10.1007/s10689-011-9506-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22187320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam.%20Cancer&amp;title=Risk%20of%20cancer%20other%20than%20breast%20or%20ovarian%20in%20individuals%20with%20BRCA1%20and%20BRCA2%20mutations&amp;author=A.%20Moran&amp;author=C.%20O%E2%80%99Hara&amp;author=S.%20Khan&amp;author=L.%20Shack&amp;author=E.%20Woodward&amp;volume=11&amp;publication_year=2012&amp;pages=235-242&amp;pmid=22187320&amp;doi=10.1007/s10689-011-9506-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-cancers-11-00295">
<span class="label">10.</span><cite>van Asperen C.J., Brohet R.M., Meijers-Heijboer E.J., Hoogerbrugge N., Verhoef S., Vasen H.F.A., Ausems M.G.E.M., Menko F.H., Gomez Garcia E.B., Klijn J.G.M., et al.  Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J. Med. Genet. 2005;42:711–719. doi: 10.1136/jmg.2004.028829.</cite> [<a href="https://doi.org/10.1136/jmg.2004.028829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1736136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16141007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Cancer%20risks%20in%20BRCA2%20families:%20estimates%20for%20sites%20other%20than%20breast%20and%20ovary&amp;author=C.J.%20van%20Asperen&amp;author=R.M.%20Brohet&amp;author=E.J.%20Meijers-Heijboer&amp;author=N.%20Hoogerbrugge&amp;author=S.%20Verhoef&amp;volume=42&amp;publication_year=2005&amp;pages=711-719&amp;pmid=16141007&amp;doi=10.1136/jmg.2004.028829&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-cancers-11-00295">
<span class="label">11.</span><cite>Farmer H., McCabe N., Lord C.J., Tutt A.N.J., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917–921. doi: 10.1038/nature03445.</cite> [<a href="https://doi.org/10.1038/nature03445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Targeting%20the%20DNA%20repair%20defect%20in%20BRCA%20mutant%20cells%20as%20a%20therapeutic%20strategy&amp;author=H.%20Farmer&amp;author=N.%20McCabe&amp;author=C.J.%20Lord&amp;author=A.N.J.%20Tutt&amp;author=D.A.%20Johnson&amp;volume=434&amp;publication_year=2005&amp;pages=917-921&amp;pmid=15829967&amp;doi=10.1038/nature03445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-cancers-11-00295">
<span class="label">12.</span><cite>Ready K., Gutierrez-Barrera A.M., Amos C., Meric-Bernstam F., Lu K., Hortobagyi G., Arun B. Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance. Breast J. 2011;17:210–212. doi: 10.1111/j.1524-4741.2010.01055.x.</cite> [<a href="https://doi.org/10.1111/j.1524-4741.2010.01055.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21294809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20J.&amp;title=Cancer%20risk%20management%20decisions%20of%20women%20with%20BRCA1%20or%20BRCA2%20variants%20of%20uncertain%20significance&amp;author=K.%20Ready&amp;author=A.M.%20Gutierrez-Barrera&amp;author=C.%20Amos&amp;author=F.%20Meric-Bernstam&amp;author=K.%20Lu&amp;volume=17&amp;publication_year=2011&amp;pages=210-212&amp;pmid=21294809&amp;doi=10.1111/j.1524-4741.2010.01055.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-cancers-11-00295">
<span class="label">13.</span><cite>Lindor N.M., Guidugli L., Wang X., Vallée M.P., Monteiro A.N.A., Tavtigian S., Goldgar D.E., Couch F.J. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) Hum. Mutat. 2012;33:8–21. doi: 10.1002/humu.21627.</cite> [<a href="https://doi.org/10.1002/humu.21627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3242438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20review%20of%20a%20multifactorial%20probability-based%20model%20for%20classification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20(VUS)&amp;author=N.M.%20Lindor&amp;author=L.%20Guidugli&amp;author=X.%20Wang&amp;author=M.P.%20Vall%C3%A9e&amp;author=A.N.A.%20Monteiro&amp;volume=33&amp;publication_year=2012&amp;pages=8-21&amp;pmid=21990134&amp;doi=10.1002/humu.21627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-cancers-11-00295">
<span class="label">14.</span><cite>Sanz D.J., Acedo A., Infante M., Durán M., Pérez-Cabornero L., Esteban-Cardeñosa E., Lastra E., Pagani F., Miner C., Velasco E.A. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin. Cancer Res. 2010;16:1957–1967. doi: 10.1158/1078-0432.CCR-09-2564.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-09-2564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20215541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=A%20high%20proportion%20of%20DNA%20variants%20of%20BRCA1%20and%20BRCA2%20is%20associated%20with%20aberrant%20splicing%20in%20breast/ovarian%20cancer%20patients&amp;author=D.J.%20Sanz&amp;author=A.%20Acedo&amp;author=M.%20Infante&amp;author=M.%20Dur%C3%A1n&amp;author=L.%20P%C3%A9rez-Cabornero&amp;volume=16&amp;publication_year=2010&amp;pages=1957-1967&amp;pmid=20215541&amp;doi=10.1158/1078-0432.CCR-09-2564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-cancers-11-00295">
<span class="label">15.</span><cite>Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 2002;3:285–298. doi: 10.1038/nrg775.</cite> [<a href="https://doi.org/10.1038/nrg775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11967553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Genet.&amp;title=Listening%20to%20silence%20and%20understanding%20nonsense:%20exonic%20mutations%20that%20affect%20splicing&amp;author=L.%20Cartegni&amp;author=S.L.%20Chew&amp;author=A.R.%20Krainer&amp;volume=3&amp;publication_year=2002&amp;pages=285-298&amp;pmid=11967553&amp;doi=10.1038/nrg775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-cancers-11-00295">
<span class="label">16.</span><cite>Houdayer C. In silico prediction of splice-affecting nucleotide variants. Methods Mol. Biol. 2011;760:269–281. doi: 10.1007/978-1-61779-176-5_17.</cite> [<a href="https://doi.org/10.1007/978-1-61779-176-5_17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21780003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20Mol.%20Biol.&amp;title=In%20silico%20prediction%20of%20splice-affecting%20nucleotide%20variants&amp;author=C.%20Houdayer&amp;volume=760&amp;publication_year=2011&amp;pages=269-281&amp;pmid=21780003&amp;doi=10.1007/978-1-61779-176-5_17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-cancers-11-00295">
<span class="label">17.</span><cite>Jian X., Boerwinkle E., Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42:13534–13544. doi: 10.1093/nar/gku1206.</cite> [<a href="https://doi.org/10.1093/nar/gku1206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4267638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25416802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=In%20silico%20prediction%20of%20splice-altering%20single%20nucleotide%20variants%20in%20the%20human%20genome&amp;author=X.%20Jian&amp;author=E.%20Boerwinkle&amp;author=X.%20Liu&amp;volume=42&amp;publication_year=2014&amp;pages=13534-13544&amp;pmid=25416802&amp;doi=10.1093/nar/gku1206&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-cancers-11-00295">
<span class="label">18.</span><cite>Moles-Fernández A., Duran-Lozano L., Montalban G., Bonache S., López-Perolio I., Menéndez M., Santamariña M., Behar R., Blanco A., Carrasco E., et al.  Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations? Front. Genet. 2018;9:366. doi: 10.3389/fgene.2018.00366.</cite> [<a href="https://doi.org/10.3389/fgene.2018.00366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6134256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30233647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Computational%20Tools%20for%20Splicing%20Defect%20Prediction%20in%20Breast/Ovarian%20Cancer%20Genes:%20How%20Efficient%20Are%20They%20at%20Predicting%20RNA%20Alterations?&amp;author=A.%20Moles-Fern%C3%A1ndez&amp;author=L.%20Duran-Lozano&amp;author=G.%20Montalban&amp;author=S.%20Bonache&amp;author=I.%20L%C3%B3pez-Perolio&amp;volume=9&amp;publication_year=2018&amp;pages=366&amp;pmid=30233647&amp;doi=10.3389/fgene.2018.00366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-cancers-11-00295">
<span class="label">19.</span><cite>Houdayer C., Caux-Moncoutier V., Krieger S., Barrois M., Bonnet F., Bourdon V., Bronner M., Buisson M., Coulet F., Gaildrat P., et al.  Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum. Mutat. 2012;33:1228–1238. doi: 10.1002/humu.22101.</cite> [<a href="https://doi.org/10.1002/humu.22101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22505045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Guidelines%20for%20splicing%20analysis%20in%20molecular%20diagnosis%20derived%20from%20a%20set%20of%20327%20combined%20in%20silico/in%20vitro%20studies%20on%20BRCA1%20and%20BRCA2%20variants&amp;author=C.%20Houdayer&amp;author=V.%20Caux-Moncoutier&amp;author=S.%20Krieger&amp;author=M.%20Barrois&amp;author=F.%20Bonnet&amp;volume=33&amp;publication_year=2012&amp;pages=1228-1238&amp;pmid=22505045&amp;doi=10.1002/humu.22101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-cancers-11-00295">
<span class="label">20.</span><cite>Campos B., Díez O., Domènech M., Baena M., Balmaña J., Sanz J., Ramírez A., Alonso C., Baiget M. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain. Hum. Mutat. 2003;22:337. doi: 10.1002/humu.9176.</cite> [<a href="https://doi.org/10.1002/humu.9176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12955719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=RNA%20analysis%20of%20eight%20BRCA1%20and%20BRCA2%20unclassified%20variants%20identified%20in%20breast/ovarian%20cancer%20families%20from%20Spain&amp;author=B.%20Campos&amp;author=O.%20D%C3%ADez&amp;author=M.%20Dom%C3%A8nech&amp;author=M.%20Baena&amp;author=J.%20Balma%C3%B1a&amp;volume=22&amp;publication_year=2003&amp;pages=337&amp;pmid=12955719&amp;doi=10.1002/humu.9176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-cancers-11-00295">
<span class="label">21.</span><cite>Claes K., Poppe B., Machackova E., Coene I., Foretova L., De Paepe A., Messiaen L. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer. 2003;37:314–320. doi: 10.1002/gcc.10221.</cite> [<a href="https://doi.org/10.1002/gcc.10221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12759930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Chromosomes%20Cancer&amp;title=Differentiating%20pathogenic%20mutations%20from%20polymorphic%20alterations%20in%20the%20splice%20sites%20of%20BRCA1%20and%20BRCA2&amp;author=K.%20Claes&amp;author=B.%20Poppe&amp;author=E.%20Machackova&amp;author=I.%20Coene&amp;author=L.%20Foretova&amp;volume=37&amp;publication_year=2003&amp;pages=314-320&amp;pmid=12759930&amp;doi=10.1002/gcc.10221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-cancers-11-00295">
<span class="label">22.</span><cite>Tesoriero A.A., Wong E.M., Jenkins M.A., Hopper J.L., Brown M.A., Chenevix-Trench G., Spurdle A.B., Southey M.C., kConFab  Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum. Mutat. 2005;26:495. doi: 10.1002/humu.9379.</cite> [<a href="https://doi.org/10.1002/humu.9379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16211554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Molecular%20characterization%20and%20cancer%20risk%20associated%20with%20BRCA1%20and%20BRCA2%20splice%20site%20variants%20identified%20in%20multiple-case%20breast%20cancer%20families&amp;author=A.A.%20Tesoriero&amp;author=E.M.%20Wong&amp;author=M.A.%20Jenkins&amp;author=J.L.%20Hopper&amp;author=M.A.%20Brown&amp;volume=26&amp;publication_year=2005&amp;pages=495&amp;pmid=16211554&amp;doi=10.1002/humu.9379&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-cancers-11-00295">
<span class="label">23.</span><cite>Bonatti F., Pepe C., Tancredi M., Lombardi G., Aretini P., Sensi E., Falaschi E., Cipollini G., Bevilacqua G., Caligo M.A. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Cancer Genet. Cytogenet. 2006;170:93–101. doi: 10.1016/j.cancergencyto.2006.05.005.</cite> [<a href="https://doi.org/10.1016/j.cancergencyto.2006.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17011978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet.%20Cytogenet.&amp;title=RNA-based%20analysis%20of%20BRCA1%20and%20BRCA2%20gene%20alterations&amp;author=F.%20Bonatti&amp;author=C.%20Pepe&amp;author=M.%20Tancredi&amp;author=G.%20Lombardi&amp;author=P.%20Aretini&amp;volume=170&amp;publication_year=2006&amp;pages=93-101&amp;pmid=17011978&amp;doi=10.1016/j.cancergencyto.2006.05.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-cancers-11-00295">
<span class="label">24.</span><cite>Chen X., Truong T.-T.N., Weaver J., Bove B.A., Cattie K., Armstrong B.A., Daly M.B., Godwin A.K. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum. Mutat. 2006;27:427–435. doi: 10.1002/humu.20319.</cite> [<a href="https://doi.org/10.1002/humu.20319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16619214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Intronic%20alterations%20in%20BRCA1%20and%20BRCA2:%20effect%20on%20mRNA%20splicing%20fidelity%20and%20expression&amp;author=X.%20Chen&amp;author=T.-T.N.%20Truong&amp;author=J.%20Weaver&amp;author=B.A.%20Bove&amp;author=K.%20Cattie&amp;volume=27&amp;publication_year=2006&amp;pages=427-435&amp;pmid=16619214&amp;doi=10.1002/humu.20319&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-cancers-11-00295">
<span class="label">25.</span><cite>Bonnet C., Krieger S., Vezain M., Rousselin A., Tournier I., Martins A., Berthet P., Chevrier A., Dugast C., Layet V., et al.  Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J. Med. Genet. 2008;45:438–446. doi: 10.1136/jmg.2007.056895.</cite> [<a href="https://doi.org/10.1136/jmg.2007.056895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18424508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Screening%20BRCA1%20and%20BRCA2%20unclassified%20variants%20for%20splicing%20mutations%20using%20reverse%20transcription%20PCR%20on%20patient%20RNA%20and%20an%20ex%20vivo%20assay%20based%20on%20a%20splicing%20reporter%20minigene&amp;author=C.%20Bonnet&amp;author=S.%20Krieger&amp;author=M.%20Vezain&amp;author=A.%20Rousselin&amp;author=I.%20Tournier&amp;volume=45&amp;publication_year=2008&amp;pages=438-446&amp;pmid=18424508&amp;doi=10.1136/jmg.2007.056895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-cancers-11-00295">
<span class="label">26.</span><cite>Vreeswijk M.P.G., Kraan J.N., van der Klift H.M., Vink G.R., Cornelisse C.J., Wijnen J.T., Bakker E., van Asperen C.J., Devilee P. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Hum. Mutat. 2009;30:107–114. doi: 10.1002/humu.20811.</cite> [<a href="https://doi.org/10.1002/humu.20811" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18693280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Intronic%20variants%20in%20BRCA1%20and%20BRCA2%20that%20affect%20RNA%20splicing%20can%20be%20reliably%20selected%20by%20splice-site%20prediction%20programs&amp;author=M.P.G.%20Vreeswijk&amp;author=J.N.%20Kraan&amp;author=H.M.%20van%20der%20Klift&amp;author=G.R.%20Vink&amp;author=C.J.%20Cornelisse&amp;volume=30&amp;publication_year=2009&amp;pages=107-114&amp;pmid=18693280&amp;doi=10.1002/humu.20811&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-cancers-11-00295">
<span class="label">27.</span><cite>Théry J.C., Krieger S., Gaildrat P., Révillion F., Buisine M.-P., Killian A., Duponchel C., Rousselin A., Vaur D., Peyrat J.-P., et al.  Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur. J. Hum. Genet. 2011;19:1052–1058. doi: 10.1038/ejhg.2011.100.</cite> [<a href="https://doi.org/10.1038/ejhg.2011.100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3190263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21673748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=Contribution%20of%20bioinformatics%20predictions%20and%20functional%20splicing%20assays%20to%20the%20interpretation%20of%20unclassified%20variants%20of%20the%20BRCA%20genes&amp;author=J.C.%20Th%C3%A9ry&amp;author=S.%20Krieger&amp;author=P.%20Gaildrat&amp;author=F.%20R%C3%A9villion&amp;author=M.-P.%20Buisine&amp;volume=19&amp;publication_year=2011&amp;pages=1052-1058&amp;pmid=21673748&amp;doi=10.1038/ejhg.2011.100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-cancers-11-00295">
<span class="label">28.</span><cite>Whiley P.J., Guidugli L., Walker L.C., Healey S., Thompson B.A., Lakhani S.R., Da Silva L.M., kConFab Investigators. Tavtigian S.V., Goldgar D.E., et al.  Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary. Hum. Mutat. 2011;32:678–687. doi: 10.1002/humu.21495.</cite> [<a href="https://doi.org/10.1002/humu.21495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4340479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21394826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Splicing%20and%20multifactorial%20analysis%20of%20intronic%20BRCA1%20and%20BRCA2%20sequence%20variants%20identifies%20clinically%20significant%20splicing%20aberrations%20up%20to%2012%20nucleotides%20from%20the%20intron/exon%20boundary&amp;author=P.J.%20Whiley&amp;author=L.%20Guidugli&amp;author=L.C.%20Walker&amp;author=S.%20Healey&amp;author=B.A.%20Thompson&amp;volume=32&amp;publication_year=2011&amp;pages=678-687&amp;pmid=21394826&amp;doi=10.1002/humu.21495&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-cancers-11-00295">
<span class="label">29.</span><cite>Acedo A., Sanz D.J., Durán M., Infante M., Pérez-Cabornero L., Miner C., Velasco E.A. Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes. Breast Cancer Res. 2012;14:R87. doi: 10.1186/bcr3202.</cite> [<a href="https://doi.org/10.1186/bcr3202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3446350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Comprehensive%20splicing%20functional%20analysis%20of%20DNA%20variants%20of%20the%20BRCA2%20gene%20by%20hybrid%20minigenes&amp;author=A.%20Acedo&amp;author=D.J.%20Sanz&amp;author=M.%20Dur%C3%A1n&amp;author=M.%20Infante&amp;author=L.%20P%C3%A9rez-Cabornero&amp;volume=14&amp;publication_year=2012&amp;pages=R87&amp;pmid=22632462&amp;doi=10.1186/bcr3202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-cancers-11-00295">
<span class="label">30.</span><cite>Gaildrat P., Krieger S., Di Giacomo D., Abdat J., Révillion F., Caputo S., Vaur D., Jamard E., Bohers E., Ledemeney D., et al.  Multiple sequence variants of BRCA2 exon 7 alter splicing regulation. J. Med. Genet. 2012;49:609–617. doi: 10.1136/jmedgenet-2012-100965.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2012-100965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22962691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Multiple%20sequence%20variants%20of%20BRCA2%20exon%207%20alter%20splicing%20regulation&amp;author=P.%20Gaildrat&amp;author=S.%20Krieger&amp;author=D.%20Di%20Giacomo&amp;author=J.%20Abdat&amp;author=F.%20R%C3%A9villion&amp;volume=49&amp;publication_year=2012&amp;pages=609-617&amp;pmid=22962691&amp;doi=10.1136/jmedgenet-2012-100965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-cancers-11-00295">
<span class="label">31.</span><cite>Menéndez M., Castellsagué J., Mirete M., Pros E., Feliubadaló L., Osorio A., Calaf M., Tornero E., del Valle J., Fernández-Rodríguez J., et al.  Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes. Breast Cancer Res. Treat. 2012;132:979–992. doi: 10.1007/s10549-011-1661-5.</cite> [<a href="https://doi.org/10.1007/s10549-011-1661-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21735045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Assessing%20the%20RNA%20effect%20of%2026%20DNA%20variants%20in%20the%20BRCA1%20and%20BRCA2%20genes&amp;author=M.%20Men%C3%A9ndez&amp;author=J.%20Castellsagu%C3%A9&amp;author=M.%20Mirete&amp;author=E.%20Pros&amp;author=L.%20Feliubadal%C3%B3&amp;volume=132&amp;publication_year=2012&amp;pages=979-992&amp;pmid=21735045&amp;doi=10.1007/s10549-011-1661-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-cancers-11-00295">
<span class="label">32.</span><cite>Thomassen M., Blanco A., Montagna M., Hansen T.V.O., Pedersen I.S., Gutiérrez-Enríquez S., Menéndez M., Fachal L., Santamariña M., Steffensen A.Y., et al.  Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Breast Cancer Res. Treat. 2012;132:1009–1023. doi: 10.1007/s10549-011-1674-0.</cite> [<a href="https://doi.org/10.1007/s10549-011-1674-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21769658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Characterization%20of%20BRCA1%20and%20BRCA2%20splicing%20variants:%20a%20collaborative%20report%20by%20ENIGMA%20consortium%20members&amp;author=M.%20Thomassen&amp;author=A.%20Blanco&amp;author=M.%20Montagna&amp;author=T.V.O.%20Hansen&amp;author=I.S.%20Pedersen&amp;volume=132&amp;publication_year=2012&amp;pages=1009-1023&amp;pmid=21769658&amp;doi=10.1007/s10549-011-1674-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-cancers-11-00295">
<span class="label">33.</span><cite>Colombo M., De Vecchi G., Caleca L., Foglia C., Ripamonti C.B., Ficarazzi F., Barile M., Varesco L., Peissel B., Manoukian S., et al.  Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations. PLoS ONE. 2013;8:e57173.  doi: 10.1371/journal.pone.0057173.</cite> [<a href="https://doi.org/10.1371/journal.pone.0057173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3579815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23451180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Comparative%20in%20vitro%20and%20in%20silico%20analyses%20of%20variants%20in%20splicing%20regions%20of%20BRCA1%20and%20BRCA2%20genes%20and%20characterization%20of%20novel%20pathogenic%20mutations&amp;author=M.%20Colombo&amp;author=G.%20De%20Vecchi&amp;author=L.%20Caleca&amp;author=C.%20Foglia&amp;author=C.B.%20Ripamonti&amp;volume=8&amp;publication_year=2013&amp;pages=e57173&amp;pmid=23451180&amp;doi=10.1371/journal.pone.0057173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-cancers-11-00295">
<span class="label">34.</span><cite>Santos C., Peixoto A., Rocha P., Pinto P., Bizarro S., Pinheiro M., Pinto C., Henrique R., Teixeira M.R. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families. J. Mol. Diagn. 2014;16:324–334. doi: 10.1016/j.jmoldx.2014.01.005.</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2014.01.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24607278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Diagn.&amp;title=Pathogenicity%20evaluation%20of%20BRCA1%20and%20BRCA2%20unclassified%20variants%20identified%20in%20Portuguese%20breast/ovarian%20cancer%20families&amp;author=C.%20Santos&amp;author=A.%20Peixoto&amp;author=P.%20Rocha&amp;author=P.%20Pinto&amp;author=S.%20Bizarro&amp;volume=16&amp;publication_year=2014&amp;pages=324-334&amp;pmid=24607278&amp;doi=10.1016/j.jmoldx.2014.01.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-cancers-11-00295">
<span class="label">35.</span><cite>Steffensen A.Y., Dandanell M., Jønson L., Ejlertsen B., Gerdes A.-M., Nielsen F.C., Hansen T. vO Functional characterization of BRCA1 gene variants by mini-gene splicing assay. Eur. J. Hum. Genet. 2014;22:1362–1368. doi: 10.1038/ejhg.2014.40.</cite> [<a href="https://doi.org/10.1038/ejhg.2014.40" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4231409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24667779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=vO%20Functional%20characterization%20of%20BRCA1%20gene%20variants%20by%20mini-gene%20splicing%20assay&amp;author=A.Y.%20Steffensen&amp;author=M.%20Dandanell&amp;author=L.%20J%C3%B8nson&amp;author=B.%20Ejlertsen&amp;author=A.-M.%20Gerdes&amp;volume=22&amp;publication_year=2014&amp;pages=1362-1368&amp;pmid=24667779&amp;doi=10.1038/ejhg.2014.40&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-cancers-11-00295">
<span class="label">36.</span><cite>Fraile-Bethencourt E., Díez-Gómez B., Velásquez-Zapata V., Acedo A., Sanz D.J., Velasco E.A. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18. PLoS Genet. 2017;13:e1006691.  doi: 10.1371/journal.pgen.1006691.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1006691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5384790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28339459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=Functional%20classification%20of%20DNA%20variants%20by%20hybrid%20minigenes:%20Identification%20of%2030%20spliceogenic%20variants%20of%20BRCA2%20exons%2017%20and%2018&amp;author=E.%20Fraile-Bethencourt&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;author=V.%20Vel%C3%A1squez-Zapata&amp;author=A.%20Acedo&amp;author=D.J.%20Sanz&amp;volume=13&amp;publication_year=2017&amp;pages=e1006691&amp;pmid=28339459&amp;doi=10.1371/journal.pgen.1006691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-cancers-11-00295">
<span class="label">37.</span><cite>Walker L.C., Whiley P.J., Houdayer C., Hansen T.V.O., Vega A., Santamarina M., Blanco A., Fachal L., Southey M.C., Lafferty A., et al.  Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines. Hum. Mutat. 2013;34:1424–1431. doi: 10.1002/humu.22388.</cite> [<a href="https://doi.org/10.1002/humu.22388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23893897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Evaluation%20of%20a%205-tier%20scheme%20proposed%20for%20classification%20of%20sequence%20variants%20using%20bioinformatic%20and%20splicing%20assay%20data:%20inter-reviewer%20variability%20and%20promotion%20of%20minimum%20reporting%20guidelines&amp;author=L.C.%20Walker&amp;author=P.J.%20Whiley&amp;author=C.%20Houdayer&amp;author=T.V.O.%20Hansen&amp;author=A.%20Vega&amp;volume=34&amp;publication_year=2013&amp;pages=1424-1431&amp;pmid=23893897&amp;doi=10.1002/humu.22388&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-cancers-11-00295">
<span class="label">38.</span><cite>Fackenthal J.D., Yoshimatsu T., Zhang B., de Garibay G.R., Colombo M., De Vecchi G., Ayoub S.C., Lal K., Olopade O.I., Vega A., et al.  Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. J. Med. Genet. 2016;53:548–558. doi: 10.1136/jmedgenet-2015-103570.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2015-103570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27060066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Naturally%20occurring%20BRCA2%20alternative%20mRNA%20splicing%20events%20in%20clinically%20relevant%20samples&amp;author=J.D.%20Fackenthal&amp;author=T.%20Yoshimatsu&amp;author=B.%20Zhang&amp;author=G.R.%20de%20Garibay&amp;author=M.%20Colombo&amp;volume=53&amp;publication_year=2016&amp;pages=548-558&amp;pmid=27060066&amp;doi=10.1136/jmedgenet-2015-103570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-cancers-11-00295">
<span class="label">39.</span><cite>Hansen T.V.O., Jønson L., Albrechtsen A., Steffensen A.Y., Bergsten E., Myrhøj T., Ejlertsen B., Nielsen F.C. Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T&gt;A/c.130T&gt;A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer. Breast Cancer Res. Treat. 2010;124:259–264. doi: 10.1007/s10549-010-0909-9.</cite> [<a href="https://doi.org/10.1007/s10549-010-0909-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20437199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Identification%20of%20a%20novel%20BRCA1%20nucleotide%204803delCC/c.4684delCC%20mutation%20and%20a%20nucleotide%20249T&gt;A/c.130T&gt;A%20(p.Cys44Ser)%20mutation%20in%20two%20Greenlandic%20Inuit%20families:%20implications%20for%20genetic%20screening%20of%20Greenlandic%20Inuit%20families%20with%20high%20risk%20for%20breast%20and/or%20ovarian%20cancer&amp;author=T.V.O.%20Hansen&amp;author=L.%20J%C3%B8nson&amp;author=A.%20Albrechtsen&amp;author=A.Y.%20Steffensen&amp;author=E.%20Bergsten&amp;volume=124&amp;publication_year=2010&amp;pages=259-264&amp;pmid=20437199&amp;doi=10.1007/s10549-010-0909-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-cancers-11-00295">
<span class="label">40.</span><cite>Muller D., Rouleau E., Schultz I., Caputo S., Lefol C., Bièche I., Caron O., Noguès C., Limacher J.M., Demange L., et al.  An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Med. Genet. 2011;12:121.  doi: 10.1186/1471-2350-12-121.</cite> [<a href="https://doi.org/10.1186/1471-2350-12-121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3198910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21939546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genet.&amp;title=An%20entire%20exon%203%20germ-line%20rearrangement%20in%20the%20BRCA2%20gene:%20pathogenic%20relevance%20of%20exon%203%20deletion%20in%20breast%20cancer%20predisposition&amp;author=D.%20Muller&amp;author=E.%20Rouleau&amp;author=I.%20Schultz&amp;author=S.%20Caputo&amp;author=C.%20Lefol&amp;volume=12&amp;publication_year=2011&amp;pages=121&amp;pmid=21939546&amp;doi=10.1186/1471-2350-12-121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-cancers-11-00295">
<span class="label">41.</span><cite>Caputo S.M., Léone M., Damiola F., Ehlen A., Carreira A., Gaidrat P., Martins A., Brandão R.D., Peixoto A., Vega A., et al.  Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer. Oncotarget. 2018;9:17334–17348. doi: 10.18632/oncotarget.24671.</cite> [<a href="https://doi.org/10.18632/oncotarget.24671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5915120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29707112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Full%20in-frame%20exon%203%20skipping%20of%20BRCA2%20confers%20high%20risk%20of%20breast%20and/or%20ovarian%20cancer&amp;author=S.M.%20Caputo&amp;author=M.%20L%C3%A9one&amp;author=F.%20Damiola&amp;author=A.%20Ehlen&amp;author=A.%20Carreira&amp;volume=9&amp;publication_year=2018&amp;pages=17334-17348&amp;pmid=29707112&amp;doi=10.18632/oncotarget.24671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-cancers-11-00295">
<span class="label">42.</span><cite>Colombo M., Lòpez-Perolio I., Meeks H.D., Caleca L., Parsons M.T., Li H., De Vecchi G., Tudini E., Foglia C., Mondini P., et al.  The BRCA2 c.68-7T&gt;A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum. Mutat. 2018;39:729–741. doi: 10.1002/humu.23411.</cite> [<a href="https://doi.org/10.1002/humu.23411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5947288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29460995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=The%20BRCA2%20c.68-7T&gt;A%20variant%20is%20not%20pathogenic:%20A%20model%20for%20clinical%20calibration%20of%20spliceogenicity&amp;author=M.%20Colombo&amp;author=I.%20L%C3%B2pez-Perolio&amp;author=H.D.%20Meeks&amp;author=L.%20Caleca&amp;author=M.T.%20Parsons&amp;volume=39&amp;publication_year=2018&amp;pages=729-741&amp;pmid=29460995&amp;doi=10.1002/humu.23411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-cancers-11-00295">
<span class="label">43.</span><cite>Santarosa M., Viel A., Boiocchi M. Splice variant lacking the transactivation domain of the BRCA2 gene and mutations in the splice acceptor site of intron 2. Genes Chromosomes Cancer. 1999;26:381–382. doi: 10.1002/(SICI)1098-2264(199912)26:4&amp;#x0003c;381::AID-GCC14&amp;#x0003e;3.0.CO;2-N.</cite> [<a href="https://doi.org/10.1002/(SICI)1098-2264(199912)26:4&amp;#x0003c;381::AID-GCC14&amp;#x0003e;3.0.CO;2-N" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10534775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Chromosomes%20Cancer&amp;title=Splice%20variant%20lacking%20the%20transactivation%20domain%20of%20the%20BRCA2%20gene%20and%20mutations%20in%20the%20splice%20acceptor%20site%20of%20intron%202&amp;author=M.%20Santarosa&amp;author=A.%20Viel&amp;author=M.%20Boiocchi&amp;volume=26&amp;publication_year=1999&amp;pages=381-382&amp;pmid=10534775&amp;doi=10.1002/(SICI)1098-2264(199912)26:4&amp;#x0003c;381::AID-GCC14&amp;#x0003e;3.0.CO;2-N&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-cancers-11-00295">
<span class="label">44.</span><cite>Milner J., Ponder B., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2. Nature. 1997;386:772–773. doi: 10.1038/386772a0.</cite> [<a href="https://doi.org/10.1038/386772a0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9126734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Transcriptional%20activation%20functions%20in%20BRCA2&amp;author=J.%20Milner&amp;author=B.%20Ponder&amp;author=L.%20Hughes-Davies&amp;author=M.%20Seltmann&amp;author=T.%20Kouzarides&amp;volume=386&amp;publication_year=1997&amp;pages=772-773&amp;pmid=9126734&amp;doi=10.1038/386772a0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-cancers-11-00295">
<span class="label">45.</span><cite>Zhang F., Fan Q., Ren K., Andreassen P.R. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol. Cancer Res. 2009;7:1110–1118. doi: 10.1158/1541-7786.MCR-09-0123.</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-09-0123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4928587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19584259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer%20Res.&amp;title=PALB2%20functionally%20connects%20the%20breast%20cancer%20susceptibility%20proteins%20BRCA1%20and%20BRCA2&amp;author=F.%20Zhang&amp;author=Q.%20Fan&amp;author=K.%20Ren&amp;author=P.R.%20Andreassen&amp;volume=7&amp;publication_year=2009&amp;pages=1110-1118&amp;pmid=19584259&amp;doi=10.1158/1541-7786.MCR-09-0123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-cancers-11-00295">
<span class="label">46.</span><cite>Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., Livingston D.M. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell. 2006;22:719–729. doi: 10.1016/j.molcel.2006.05.022.</cite> [<a href="https://doi.org/10.1016/j.molcel.2006.05.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16793542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Control%20of%20BRCA2%20cellular%20and%20clinical%20functions%20by%20a%20nuclear%20partner,%20PALB2&amp;author=B.%20Xia&amp;author=Q.%20Sheng&amp;author=K.%20Nakanishi&amp;author=A.%20Ohashi&amp;author=J.%20Wu&amp;volume=22&amp;publication_year=2006&amp;pages=719-729&amp;pmid=16793542&amp;doi=10.1016/j.molcel.2006.05.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-cancers-11-00295">
<span class="label">47.</span><cite>Azzollini J., Scuvera G., Bruno E., Pasanisi P., Zaffaroni D., Calvello M., Pasini B., Ripamonti C.B., Colombo M., Pensotti V., et al.  Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study. Eur. J. Intern. Med. 2016;32:65–71. doi: 10.1016/j.ejim.2016.03.010.</cite> [<a href="https://doi.org/10.1016/j.ejim.2016.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27062684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Intern.%20Med.&amp;title=Mutation%20detection%20rates%20associated%20with%20specific%20selection%20criteria%20for%20BRCA1/2%20testing%20in%201854%20high-risk%20families:%20A%20monocentric%20Italian%20study&amp;author=J.%20Azzollini&amp;author=G.%20Scuvera&amp;author=E.%20Bruno&amp;author=P.%20Pasanisi&amp;author=D.%20Zaffaroni&amp;volume=32&amp;publication_year=2016&amp;pages=65-71&amp;pmid=27062684&amp;doi=10.1016/j.ejim.2016.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-cancers-11-00295">
<span class="label">48.</span><cite>Pinto C., Bella M.A., Capoluongo E., Carrera P., Clemente C., Colombo N., Cortesi L., De Rosa G., Fenizia F., Genuardi M., et al.  Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients. Future Oncol. 2016;12:2071–2075. doi: 10.2217/fon-2016-0189.</cite> [<a href="https://doi.org/10.2217/fon-2016-0189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27241581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Future%20Oncol.&amp;title=Recommendations%20for%20the%20implementation%20of%20BRCA%20testing%20in%20the%20care%20and%20treatment%20pathways%20of%20ovarian%20cancer%20patients&amp;author=C.%20Pinto&amp;author=M.A.%20Bella&amp;author=E.%20Capoluongo&amp;author=P.%20Carrera&amp;author=C.%20Clemente&amp;volume=12&amp;publication_year=2016&amp;pages=2071-2075&amp;pmid=27241581&amp;doi=10.2217/fon-2016-0189&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-cancers-11-00295">
<span class="label">49.</span><cite>Shapiro M.B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155–7174. doi: 10.1093/nar/15.17.7155.</cite> [<a href="https://doi.org/10.1093/nar/15.17.7155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC306199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3658675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=RNA%20splice%20junctions%20of%20different%20classes%20of%20eukaryotes:%20sequence%20statistics%20and%20functional%20implications%20in%20gene%20expression&amp;author=M.B.%20Shapiro&amp;author=P.%20Senapathy&amp;volume=15&amp;publication_year=1987&amp;pages=7155-7174&amp;pmid=3658675&amp;doi=10.1093/nar/15.17.7155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-cancers-11-00295">
<span class="label">50.</span><cite>Yeo G., Burge C.B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004;11:377–394. doi: 10.1089/1066527041410418.</cite> [<a href="https://doi.org/10.1089/1066527041410418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15285897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Biol.&amp;title=Maximum%20entropy%20modeling%20of%20short%20sequence%20motifs%20with%20applications%20to%20RNA%20splicing%20signals&amp;author=G.%20Yeo&amp;author=C.B.%20Burge&amp;volume=11&amp;publication_year=2004&amp;pages=377-394&amp;pmid=15285897&amp;doi=10.1089/1066527041410418&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-cancers-11-00295">
<span class="label">51.</span><cite>Reese M.G., Eeckman F.H., Kulp D., Haussler D. Improved splice site detection in Genie. J. Comput. Biol. 1997;4:311–323. doi: 10.1089/cmb.1997.4.311.</cite> [<a href="https://doi.org/10.1089/cmb.1997.4.311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9278062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Biol.&amp;title=Improved%20splice%20site%20detection%20in%20Genie&amp;author=M.G.%20Reese&amp;author=F.H.%20Eeckman&amp;author=D.%20Kulp&amp;author=D.%20Haussler&amp;volume=4&amp;publication_year=1997&amp;pages=311-323&amp;pmid=9278062&amp;doi=10.1089/cmb.1997.4.311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-cancers-11-00295">
<span class="label">52.</span><cite>Pertea M., Lin X., Salzberg S.L. GeneSplicer: A new computational method for splice site prediction. Nucleic Acids Res. 2001;29:1185–1190. doi: 10.1093/nar/29.5.1185.</cite> [<a href="https://doi.org/10.1093/nar/29.5.1185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC29713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11222768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=GeneSplicer:%20A%20new%20computational%20method%20for%20splice%20site%20prediction&amp;author=M.%20Pertea&amp;author=X.%20Lin&amp;author=S.L.%20Salzberg&amp;volume=29&amp;publication_year=2001&amp;pages=1185-1190&amp;pmid=11222768&amp;doi=10.1093/nar/29.5.1185&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-cancers-11-00295">
<span class="label">53.</span><cite>Desmet F.-O., Hamroun D., Lalande M., Collod-Béroud G., Claustres M., Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67. doi: 10.1093/nar/gkp215.</cite> [<a href="https://doi.org/10.1093/nar/gkp215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2685110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19339519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Human%20Splicing%20Finder:%20an%20online%20bioinformatics%20tool%20to%20predict%20splicing%20signals&amp;author=F.-O.%20Desmet&amp;author=D.%20Hamroun&amp;author=M.%20Lalande&amp;author=G.%20Collod-B%C3%A9roud&amp;author=M.%20Claustres&amp;volume=37&amp;publication_year=2009&amp;pages=e67&amp;pmid=19339519&amp;doi=10.1093/nar/gkp215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-cancers-11-00295">
<span class="label">54.</span><cite>Colombo M., Blok M.J., Whiley P., Santamariña M., Gutiérrez-Enríquez S., Romero A., Garre P., Becker A., Smith L.D., De Vecchi G., et al.  Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: A report from the ENIGMA consortium. Hum. Mol. Genet. 2014;23:3666–3680. doi: 10.1093/hmg/ddu075.</cite> [<a href="https://doi.org/10.1093/hmg/ddu075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24569164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Comprehensive%20annotation%20of%20splice%20junctions%20supports%20pervasive%20alternative%20splicing%20at%20the%20BRCA1%20locus:%20A%20report%20from%20the%20ENIGMA%20consortium&amp;author=M.%20Colombo&amp;author=M.J.%20Blok&amp;author=P.%20Whiley&amp;author=M.%20Santamari%C3%B1a&amp;author=S.%20Guti%C3%A9rrez-Enr%C3%ADquez&amp;volume=23&amp;publication_year=2014&amp;pages=3666-3680&amp;pmid=24569164&amp;doi=10.1093/hmg/ddu075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-cancers-11-00295">
<span class="label">55.</span><cite>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</cite> [<a href="https://doi.org/10.1006/meth.2001.1262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11846609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Analysis%20of%20relative%20gene%20expression%20data%20using%20real-time%20quantitative%20PCR%20and%20the%202(-Delta%20Delta%20C(T))%20Method&amp;author=K.J.%20Livak&amp;author=T.D.%20Schmittgen&amp;volume=25&amp;publication_year=2001&amp;pages=402-408&amp;pmid=11846609&amp;doi=10.1006/meth.2001.1262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-cancers-11-00295">
<span class="label">56.</span><cite>Forzan M., Salviati L., Pertegato V., Casarin A., Bruson A., Trevisson E., Di Gianantonio E., Clementi M. Is CFTR 621+3 A&gt;G a cystic fibrosis causing mutation? J. Hum. Genet. 2010;55:23–26. doi: 10.1038/jhg.2009.115.</cite> [<a href="https://doi.org/10.1038/jhg.2009.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19893581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Is%20CFTR%20621+3%20A&gt;G%20a%20cystic%20fibrosis%20causing%20mutation?&amp;author=M.%20Forzan&amp;author=L.%20Salviati&amp;author=V.%20Pertegato&amp;author=A.%20Casarin&amp;author=A.%20Bruson&amp;volume=55&amp;publication_year=2010&amp;pages=23-26&amp;pmid=19893581&amp;doi=10.1038/jhg.2009.115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57-cancers-11-00295">
<span class="label">57.</span><cite>Fallerini C., Baldassarri M., Trevisson E., Morbidoni V., La Manna A., Lazzarin R., Pasini A., Barbano G., Pinciaroli A.R., Garosi G., et al.  Alport syndrome: impact of digenic inheritance in patients management. Clin. Genet. 2017;92:34–44. doi: 10.1111/cge.12919.</cite> [<a href="https://doi.org/10.1111/cge.12919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27859054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Alport%20syndrome:%20impact%20of%20digenic%20inheritance%20in%20patients%20management&amp;author=C.%20Fallerini&amp;author=M.%20Baldassarri&amp;author=E.%20Trevisson&amp;author=V.%20Morbidoni&amp;author=A.%20La%20Manna&amp;volume=92&amp;publication_year=2017&amp;pages=34-44&amp;pmid=27859054&amp;doi=10.1111/cge.12919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58-cancers-11-00295">
<span class="label">58.</span><cite>de la Hoya M., Soukarieh O., López-Perolio I., Vega A., Walker L.C., van Ierland Y., Baralle D., Santamariña M., Lattimore V., Wijnen J., et al.  Combined genetic and splicing analysis of BRCA1 c.[594-2A&gt;C; 641A&gt;G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum. Mol. Genet. 2016;25:2256–2268. doi: 10.1093/hmg/ddw094.</cite> [<a href="https://doi.org/10.1093/hmg/ddw094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5081057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27008870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Combined%20genetic%20and%20splicing%20analysis%20of%20BRCA1%20c.%5B594-2A&gt;C;%20641A&gt;G%5D%20highlights%20the%20relevance%20of%20naturally%20occurring%20in-frame%20transcripts%20for%20developing%20disease%20gene%20variant%20classification%20algorithms&amp;author=M.%20de%20la%20Hoya&amp;author=O.%20Soukarieh&amp;author=I.%20L%C3%B3pez-Perolio&amp;author=A.%20Vega&amp;author=L.C.%20Walker&amp;volume=25&amp;publication_year=2016&amp;pages=2256-2268&amp;pmid=27008870&amp;doi=10.1093/hmg/ddw094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/6468917/bin/cancers-11-00295-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (2.1MB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cancers are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/cancers11030295"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cancers-11-00295.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/6468917/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/6468917/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6468917%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6468917/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC6468917/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC6468917/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/30832263/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC6468917/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/30832263/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC6468917/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/6468917/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Z1xvqh6Z9oVigTneqYnWYkedTK94U5V9BbXIc9zxq6pCrZSfGXLwvs7T0CyhXQqE">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
